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Atrial fibrillation (AF) is the most common arrhythmia in human and its incidence is 
under-diagnosed because many episodes of AF are asymptomatic.1 AF is associated with 
an increased chance of stroke and thromboembolic events.2 Furthermore, because of 
its association with several age-related co-morbidities such as hypertension, diabetes 
mellitus, obesity and cardiac disease, its incidence is rising.3 In general, AF is categorized 
into paroxysmal (self-terminating), persistent (non-self-terminating, but pharmacologi-
cal cardioversion still possible) and permanent (not amenable to pharmacological cardi-
oversion) forms.4 In addition, postoperative AF (POAF) episodes occur after major sur-
gery, mainly after cardiac surgery5 in patients with a comparable risk profile as in non-
surgical AF. 6, 7  
The degree of atrial wall remodelling and occurrence of triggers determine the 
number and duration of AF episodes. Co-morbidities and advanced age contribute to 
structural heart disease, which leads to atrial wall remodelling and AF perpetuation.8, 9 
This is illustrated for example in CHADS2VA2Sc and HATCH scores 
10, 11 both of which 
increase the chances of AF progression. The resulting multifactorial aetiology of AF 
includes abnormalities in calcium handling, ion-channel remodelling, fibrosis, oxidative 
stress, inflammation and others.12  
Assessment of the atrial electrical activation during AF (Figure 1) has revealed that 
the fibrillation conduction pattern becomes more complex with AF persistence and is a 
reflection of the underlying structural changes.12-14 Moreover, different underlying dis-
eases lead to distinctly different patterns of structural remodelling and fibrillation pat-
terns in animal models.15 Two very interesting observations in human AF and AF animal 
models are dyssynchronous activation of the endo-epicardial surface (endo-epicardial 
dissociation) of the thin atrial wall, which leads to transmural conduction of wavelets 
(breakthrough). These conduction patterns have been shown to increase with complex 
substrates for AF in goat models16 and in humans, with high inter-individual variability 
(Figure 2).14  
Figure 1 Different steps in epicardial mapping of fibrillation waves: From left to right: a unipolar electrode 
array (26 x 26 mm) is used to record epicardial electrical activation by placing the electrode on the atrial wall 
surface during (induced) AF; unipolar electrograms are recorded and processed using an automated algorithm 
to filter out farfield deflections and detect steepest local deflections; finally, using the conduction velocity and 
wave tortuosity a wave map is created from the activation map (coloured arrows depict individual waves). 
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Furthermore, AF itself can cause a gradual progression of structural changes such as 
myofiber rearrangement17 and endomysial fibrosis18 that contribute to AF perpetuation.  
As expected, the traditional view of AF as a “one size fits all” disease does not suffice 
in classifying this complex disorder. This has become clearer from particularly two im-
portant findings of continuous rhythm monitoring devices (i.e. implanted pacemakers 
with atrial leads or implantable loop recorders). First, it has been shown that there is 
great discrepancy between the clinical classification of AF, which is often based on 
symptomatology, and the true temporal persistence of AF.19 In other words, patients 
classified in identical clinical categories may in reality have a wide variety in duration 
and incidence of AF episodes, which can lead to underestimation of the true AF burden. 
This finding may have important implications in clinical risk stratification, treatment 
strategies and their outcome measures in the abovementioned categories.  Second, and 
perhaps even more importantly, subclinical atrial high rate episodes (AHRE) detected 
from implanted pacemakers, lasting up to 6 minutes contribute to enhanced risk of 
stroke.1, 20, 21 Consequently, even short lasting AF episodes may require oral anticoagula-
tion treatment underscoring the need for rhythm monitoring in patients at risk for 
stroke. Thus, advanced monitoring strategies have led to a quest for re-evaluation of 
the clinical classifications of AF.  
 
 
Figure 2 Two representative examples of activation patterns during electrically induced AF, acquired from 
patients without a history of AF: On the left, a 59 year old male patient with hypertension who underwent 
coronary artery bypass graft (CABG); On the right a 69 year old patient with hypertension who underwent 
CABG. Different colours depict different waves, arrows depict wave propagation direction, asterisks depict 
breakthrough waves. Clearly a more complex propagation pattern with wave narrowing and breakthroughs 
are seen in the older patient on the right (see also Chapter 4). 
 
In this context, patients without a history of AF undergoing cardiac surgery represent a 
unique population. These patients carry on the one hand various degrees of potential 
substrates for AF caused by a variety of co-morbidities such as hypertension, cardiac 
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failure and myocardial infarction. On the other hand, AF occurs in these patients during 
the acute postoperative phase by a large number of triggers including acute hemody-
namic instability causing atrial stretch, a systemic inflammatory response to cardiopul-
monary bypass, high levels of sympathetic activation, and others.5,22-26  
Notably, while POAF is thought of as a transient arrhythmia after cardiac surgery, it 
is associated with increased long-term mortality and risk of stroke.6, 7 This indicates that 
POAF may not be confined to the acute phase triggers but may show late recurrences, 
which is plausible if there is an underlying substrate. Also, whether the substrate for 
late POAF develops as a result of surgery or is pre-existent may differ from patient to 
patient. On the one hand, POAF occurs more frequently after cardiac surgery as op-
posed to general surgery, emphasizing the importance of cardiac surgical 
manipulation.27 On the other hand, analysis of right atrial appendages before and after 
surgery does not show histopathological differences.28 Furthermore up to 90% of pa-
tients with severe pre-existing myolysis develop POAF.28 These findings alongside the 
abovementioned co-morbidities in patients undergoing cardiac surgery, suggest a pre-
existing substrate that predisposes patients to POAF as opposed to an acute change 
during the operation (Figure 3).  
 
 
Figure 3 Schematic representation of a pre-existing structural substrate and its influence on vulnerability to 
POAF. Curved arrows depict electrical propagation, POAF= postoperative atrial fibrillation 
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S c o p e  o f  t h i s  t h e s i s  
In this thesis, we describe a number of studies undertaken to characterize the electro-
physiological properties of the AF substrate during and after cardiac surgery, including a 
thorough quantification of true AF burden for an extended period of time after surgery. 
For this purpose we used continuous rhythm monitoring devices to detect AF episodes 
during follow-up periods of 1 month up to 3 years after cardiac surgery.  
Previous studies quantifying late POAF mostly discuss clinical AF recurrences in pop-
ulations who had a history of AF or show symptomatic and long lasting AF episodes. 
Here, we studied the relation between clinical predisposition at baseline and the elec-
tropathological substrate for AF on the one hand and AF recurrences including short 
lasting subclinical AF episodes on the other hand. Next to the invasive substrate quanti-
fication during surgery, we also highlight less invasive methods of substrate quantifica-
tion such as P-wave morphology in electrocardiograms.  
In the light of the above-mentioned inter-individual variability in AF substrates, de-
tailed computational models can incorporate specific structural changes and atrial re-
modeling, to assess their effects on the propagation properties. In the last chapters of 
this thesis we describe the complex 3-dimensional electropathological substrate for AF 
in humans using a highly detailed computer model of AF, which showed the occurrenc-
es of transmural propagation of breakthrough waves as a result of endo-epicardial elec-
trical uncoupling. To test this, we developed an invasive mapping technique, in which a 
clamp like electrode was inserted into the right atrium prior to venous cannulation 
during cardiac surgery to map the endo- and epicardium simultaneously. Using these 
techniques, we detected a new dimension in the electropathological substrate of AF.  
 
In summary, we discuss the following subjects in the different chapters of this thesis: 
- The prevalence of new onset AF in the acute postoperative phase (early POAF) and 
during prolonged follow-up (late POAF) using continuous rhythm monitoring devices 
(Chapters 3-4) 
- Effect of co-morbidities on incidence of early and late POAF in the patients undergo-
ing open chest cardiac surgery (Chapters 2-4,7) 
- The underlying electropathological substrate assessed during electrically induced AF 
for POAF and late POAF in patients without a history of AF (Chapter 4). 
- The 3-dimensional substrate for AF in patients undergoing open chest surgery 
(Chapter 5-6).  
- ECG parameters for substrate detection and POAF prediction in patients undergoing 
cardiac surgery (Chapter 4). 
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A b s t r a c t  
Atrial fibrillation occurring after cardiac surgery has been the subject of intensive re-
search over the past decades. However, the incidence remains high, despite numerous 
preventive and treatment strategies. In addition, several reports show that the impact 
of postoperative atrial fibrillation (POAF) is high. It is an independent risk factor for 
mortality after several years. These findings make clear that the pathophysiology of 
POAF is not fully understood and POAF-associated risks to some extent might be under-
estimated. On the one hand, excessive triggers during the acute post operative phase 
after cardiac surgery might initiate AF even in atria with low vulnerability. On the other 
hand, many patients undergoing surgery have an atrial substrate at the time of opera-
tion promoting AF not only in the postoperative phase but also in the days and weeks 
thereafter. Progress in our understanding of the AF mechanisms in general has provided 
valuable insights into processes involved in atrial structural remodeling due to advanced 
age, hypertension, obesity, and congestive heart failure. These patient characteristics 
strongly contribute to cardiac disease, predict POAF and likely have an impact on the 
risk of thrombus formation in the weeks and months after cardiac surgery. For a better 
understanding of the mechanisms involved, it is important to not only recognize the 
occurrence of POAF by continuous monitoring after surgery, but also to identity the 
extent of atrial vulnerability to AF in these patients. 
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I n t r o d u c t i o n  a n d  I n c i d e n c e  
Postoperative atrial fibrillation (POAF) is an important complication after cardiac sur-
gery, which increases short-term hospitalization costs 1 and more importantly, decreas-
es long-term survival. 2, 3 This makes POAF an important target for prevention and 
treatment.  
Great discrepancy remains between reported incidences of POAF in different stud-
ies. Reported incidences vary between 10-60% depending on the type of surgery, with 
higher incidences in valve surgery compared to coronary artery bypass surgery (CABG). 4 
This is certainly affected by the more invasive structural changes arising from valvular 
diseases such as atrial dilatation and fibrosis, but also by the more prolonged and inva-
sive nature of the surgical interventions in valve surgery.5 The incidence of POAF is 
however also influenced by the definition of AF. The minimal duration of AF needed to 
qualify as POAF varies in reports between minutes of AF,6, 7 to sometimes only qualifica-
tion as AF if it requires therapy.1  
In general, AF is defined as an episode with irregular RR-intervals without a tracea-
ble p-wave, during at least 10 seconds.8, 9 It is important to acknowledge even the short 
episodes of AF,6 because of the progressive nature of the arrhythmia,10, 11 but also be-
cause even a low AF burden significantly increases the stroke rate.12 The unpredictabil-
ity of AF onset and duration poses a great challenge to the intermittent rhythm detec-
tors such as ECG or Holter monitoring after discharge.13 Reports on long-term follow up 
after cardiac surgery suggest that POAF is an independent predictor of mortality, which 
might well be related to the fact that it is a recurrent arrhythmia.2, 3, 14 Of note, some of 
the AF episodes may remain unnoticed as they can be asymptomatic both during hospi-
talization and after discharge.15-17  
Indeed, several studies in patients undergoing cardiac surgery have shown recur-
rence of AF after discharge.18, 19 In a randomized trial of 124 patients on the effects of 
Amiodarone after cardiac surgery, 12% of the patients in the placebo group were in AF 
at a mean of 12 days after discharge.20 In a retrospective study of 305 patients undergo-
ing cardiac surgery, the annual incidence of symptomatic AF during a 4 year follow up 
was 5.1% in patients who had developed POAF.21 Interestingly, multivariate analysis 
showed reduced left ventricular ejection fraction, which can cause atrial structural re-
modelling, to predict recurrences of POAF independently.21 In line with this, other pre-
dictors of POAF after discharge that have been reported are valve surgery, history of 
myocardial infarction and pulmonary hypertension.17  
The value of continuous monitoring seems essential in detecting the true POAF bur-
den,13 because the importance of asymptomatic “silent AF” in patients with a compara-
ble risk profile as the POAF population, has recently been emphasized.12 Therefore, to 
be able to treat or at least to restrain the consequences of POAF, a better understand-
ing of the pathophysiology of POAF is mandatory.  
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P a t h o p h y s i o l o g y  
Even in normal atria in sinus rhythm inter-atrial and site-specific conduction delays 
occur, leading to spatial non-uniformity of conduction anisotropy.22 In the presence of 
triggers with sufficient incidence, AF can be induced both in normal and in abnormal 
atria. The wave pattern and type of AF however, may vary in complexity 9 depending on 
the severity of the underlying substrate.23 Although inducibility of AF by pacing in nor-
mal atrial structure is dependent on the protocol of pacing, 24 it has predictive value for 
the occurrence of POAF.25, 26 This suggests higher susceptibility for AF at least in some of 
the patients who subsequently develop POAF.27 Furthermore, AF occurring as a conse-
quence of cardiac surgery in patients without a history of AF postulates a significant 
pathophysiological role for the surgical intervention itself.  
Early pro-arrhythmic environment 
In a recent review, we discussed the acute and chronic factors contributing to initiation 
of POAF, and emphasized that different mechanisms are responsible for AF in the acute 
post operative setting.28 
Inflammation in the postoperative phase has been subject of extensive research as it 
has been linked to several local and systemic pro-arrhythmic effects. First of all, direct 
atrial trauma, e.g. the venous cannulation through the right atrium, has been shown to 
induce an inflammatory reaction leading to inhomogeneity in conduction in a canine 
model.29 The canine sterile pericarditis model, in which application of sterile talc and 
subsequent pericarditis enhanced AF susceptibility, supports this hypothesis.30 Admin-
istration of prednisone in this model reduced inflammation and as expected prevented 
AF.31 Similarly colchicine was able to reduce the incidence of POAF, as a result of a re-
duction of the post-cardiotomy syndrome in humans. 32 Secondly, systemic inflammato-
ry effects expressed as increased C-reactive protein levels, and therefore complement 
activation during cardio pulmonary bypass and during the acute post operative phase, 
were demonstrated to coincide with the peak POAF incidence, advocating a direct im-
mune reaction mediated by the complement system.33 Indeed, the use of cardio pul-
monary bypass is correlated with POAF incidence in most studies.5, 34 Thus as expected, 
oral corticosteroids reduce not only the postoperative inflammatory markers, but also 
the incidence of POAF as demonstrated by an extensive meta-analysis.35 
Furthermore, cardiopulmonary bypass might lead to insufficient cooling of the atria 
during the cardioplegic arrest.36 This may induce a temporary substrate to initiate AF as 
a consequence of ischemia reperfusion injury.36, 37 Indeed, oxidative stress has been 
shown to cause a transient pro-arrhythmic effect in the postoperative setting.38 This can 
explain the anti-arrhythmic effects of statins in POAF prevention. Despite the anti-
inflammatory effects of the HMG-CoA enzyme inhibitors, statins had no effect in prede-
termined substrates for AF, such as enlarged left atria.39 In line with the effect of oxida-
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tive stress in the direct postoperative occurrence of AF, administration of ascorbate acid 
preserved the length of the effective refractory period (ERP) during rapid pacing in a 
canine model, and reduced POAF especially in the very early postoperative phase in 
humans.40 Similarly, the antioxidant N-acetylcysteine reduced the incidence of POAF in 
the early postoperative phase.41 These findings suggest that independent of a pre-
existing vulnerability to AF, surgery itself can have several pro-arrhythmic consequences 
on the atrial tissue based on ischemic and inflammatory effects.  
Postoperatively, as a counterbalance to anaesthesia induced hypotension, systemic 
inflammatory response and cardiac stunning after aortic cross clamping fluid admin-
istration is required to keep up the cardiac output. Especially in hypertrophic ventricles, 
e.g. in aortic valve stenosis, significant volume therapy is applied for hemodynamic 
stabilization in the acute post-operative phase. In this setting, atrial enlargement seems 
to be an important factor in predicting POAF.32 Acute atrial stretch decreases conduc-
tion velocity, increases conduction block and thereby the vulnerability of the atrial tis-
sue to re-entry.42-44 In addition, premature atrial beats initiate postoperative AF,45 partly 
aggravated by high sympathetic activation.6 Possibly they are also due to increased L-
type calcium currents (Ica
2+) in patients developing POAF.46 Indeed, milrinone, a phos-
phodiesterase inhibitor inotropic agent, increased the incidence of POAF significantly, 
presumably through a protein kinase-A activation leading to triggered activity. 47 
It can be concluded that transient local and systemic changes in the acute post-
operative phase after cardiac surgery are linked to POAF. They cause conduction dis-
turbances and may enhance triggers for AF both of which together will enhance the 
susceptibility to AF. 
Histopathological substrate  
In addition to postoperative acute phase triggers, several long-term mechanisms have 
been identified to also predict POAF. These mechanisms are known to produce a more 
sustained substrate for AF, which favors AF maintenance rather than initiating it. The 
complexity of AF in these patients is therefore higher and recurrences are more likely 
after discharge, compared to AF in the less pronounced substrates, which are confined 
to solely acute phase POAF. 
First, POAF is a disease of advanced age.1, 48 The atrial wall becomes fibrotic with 
age49 and this has been identified as one of the most important structural substrates for 
AF perpetuation in the non-operative setting.10, 23 Prolonged signal averaged p-wave 
duration may reflect atrial fibrosis resulting in conduction delays and has been reported 
to be a predictor of POAF.50-52 However, pre-operative AF was not excluded in all these 
studies.50, 51 Nevertheless this finding suggests an increased AF vulnerability in patients 
with intra-atrial conduction delays particularly in a pro-arrhythmic environment.  
Several co-morbidities have also been shown to increase the chances of POAF de-
velopment, such as chronic obstructive pulmonary disease,48, 53 hypertension, obesity 
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and systolic dysfunction.1, 53 The role of these co-morbidities in the perpetuation of AF 
has long been established.8, 54 Obesity has been associated with ERP shortening in left 
atria, diastolic dysfunction and left atrial dilation, all of which predispose to AF.5  
In congestive heart failure, Sanders et al. demonstrated increased vulnerability to AF 
due to prolonged P-wave duration, prolonged ERP duration at the right atrial wall and 
significantly longer sinus node recovery time.27 Accordingly, prolongation of conduction 
time with a higher percentage of double potentials and longer iso-electric intervals is 
linked to severely disturbed substrates. 10, 23 These pro-arrhythmic changes seem to 
occur due to chronic dilated atria, as a consequence of congestive heart failure or 
longstanding valve pathology for example. In line with these findings, left ventricular 
diastolic dysfunction was determined as an additional predictor of POAF.55 On the bio-
chemical level, stretch activated channels (SAC’s) increase intracellular Na+ concentra-
tions. As a consequence, the Na+/Ca2+ exchanger extrudes less Ca2+ to the extracellular 
space, thereby enhancing Ca2+ binding to the actin-myosin response. In this setting 
intracellular calcium overload causes a down regulation of Ica
2+-gene expression, subse-
quently shortening the ERP.56 Also chronic stretch has been associated with altered 
matrix metalloproteinase expression and angiotensin II mediated fibrosis.10 Thus as 
expected preoperative atrial enlargement has been shown to increase risk for POAF. 57 
Furthermore, preoperative dispersion of refractoriness and a prolonged PR interval 
predicted POAF after CABG.58 Atrial structural changes have also been attributed to the 
uncontrolled ventricular rate and congestive heart failure leading to atrial stretch, apop-
tosis and myolysis.59 Although apoptosis has not consistently been found in the atrial 
tissue of patients developing POAF, myolysis has been advocated as a pre-existing struc-
tural substrate in these patients.60, 61  
Another important structural abnormality, which is closely linked to the propagating 
abilities of the atrial wall, is the gap-junctional connexin (Cx) distribution. Higher and 
more heterogeneously distributed levels of Cx 40 have been demonstrated in POAF 
patients.62 Also local inflammation caused a reduction in Cx 40 and 43 expressions in 
the epicardial level, compared to normal distribution in non-inflammatory circumstanc-
es.63 The exact role of connexin expression changes in POAF still needs to be defined. 
From these findings it can be concluded that at least in some of the patients devel-
oping POAF after cardiac surgery, severely altered atrial architecture already is present 
before the operation. These structural alterations make the atria prone to not only 
POAF but also to AF in general. This is important because POAF might be an expression 
of the atrial vulnerability that is detected due to continuous monitoring in a period with 
excessive triggers, a “poor man’s exercise” effect. This strongly implies close monitoring 
of these patients later on. Figure 1 gives a possible course of POAF development and 
perpetuation after cardiac surgery and after discharge.  
Treatment strategies also provide additional information for the possible mecha-
nism that is responsible for POAF. The positive effects of class III anti arrhythmic drugs 
for example, suggest a role for a re-entry mechanism, in which shortening of the excita-
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ble gap might be the key element in their effectiveness, while beta-adrenergic blockers 
advocate a more prominent role for the sympathetic activation and triggers for AF.5, 64  
 
 
Figure 1 A schematic sketch of incidence of POAF in the early postoperative phase (i.e. the first post-
operative week) and during the late postoperative phase (i.e. weeks to years following cardiac surgery) after 
discharge. In severely aggravated atrial substrates, POAF might continue to exist and reoccur. Red area under 
the curve represents patients with a preexistent structural substrate, e.g. atrial enlargement or heart failure, 
which is not easily reversible. White area under the curve represents patients with less severe structural 
substrate but who are exposed to the pro-arrhythmic environment of the acute-postoperative phase.  
P r e v e n t i o n  
Beta-Blockers 
It has become clear from multiple meta-analyses, reviews, and large cohort studies, that 
the peri-operative use of β-blocking agents reduces the incidence of atrial fibrillation 
after cardiac surgery.65-67 Furthermore, it is evident that the peri-operative use of β-
blockers reduces mortality.66 This knowledge has led to unambiguous recommendations 
of the use of β -blockers as standard of care in the prophylaxis of POAF in patients with-
out contra-indications.8, 68-70 
Sotalol 
Sotalol has a greater efficacy in preventing POAF than standard β-blockers,65 but has 
possibly more unfavorable adverse event profile. The extent of side effects of sotalol, 
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such as prolongation of the QT-interval, compared to standard β-blockers is debated.  
Because sotalol exposes patients to the risk for torsade des pointes, its use requires 
close monitoring, and under these conditions may be considered for the prevention of 
POAF. 8, 54, 68, 70 
Amiodarone 
Amiodarone with its class III anti-arrhythmic effects is a strong preventive drug in the 
acute postoperative setting.20, 71 Prophylactic amiodarone, with or without concomitant 
use of β-blockers also has a positive effect on duration of hospital stay, postoperative 
stroke, and postoperative ventricular tachyarrhythmia.20, 65, 71-73 However, in one trial 
the effects of amiodarone were not superior to placebo in patients with enlarged atria 
and in patients undergoing valve surgery. These are important characteristics of pa-
tients with a strong structural substrate43, 71 suggesting its effectiveness relies on the 
prevention of triggers in the early pro-arrhythmic environment. Common adverse ef-
fects of amiodarone are bradycardia and hypotension,74, 75 which lead- together with 
extra cardiac side effects- to cessation of the treatment in up to 20% of all patients.76 
The pre-operative administration of amiodarone should be considered in patients with 
high risk for the development of POAF, according to the international guidelines,8, 54 and 
should certainly be considered in patients with a contraindication for the use of β-
blockers.68, 70 
Biatrial pacing 
Bi-atrial pacing significantly reduces the incidence of POAF,65, 73 although it has been 
reported to be difficult to apply. Some studies demonstrated even pro-arrhythmic side 
effects and also unintentional diaphragmatic or left ventricular pacing are common.52, 77-
79 However, when sensing and capture thresholds of the pacemaker leads are followed 
accurately, particularly simultaneous biatrial pacing effectively prevents POAF. 7, 80-84 
The main effects of postoperative atrial pacing on the atria are still unclear. It has been 
proposed that simultaneous biatrial pacing reduces dispersion of refractoriness and 
reduces the P-wave duration and dispersion. 52, 85 Also, overdrive pacing might prevent 
ectopic activity.82 At the ventricular level, overdrive pacing after an ischemic episode 
has been shown to reduce infarct size, based on prevention of ischemic reperfusion 
injury.86 More research is required to define the exact mechanisms of AF prevention by 
pacing at the atrial level, and to determine the population in which pacing is effective.   
ACE-inhibitors 
Angiotensin concerting enzyme inhibitors (ACEI’s) may be as effective in preventing 
POAF as they are in permanent AF in general population.87 Although administration of 
ACEI’s have been associated with reduced POAF incidence,48, 88 recent reports show 
conflicting results. Most importantly increased adverse effects are reported in some 
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studies, including hypotension, renal failure, higher mortality and a paradoxical in-
creased risk of POAF incidence,89, 90 or at least no reduction of new onset AF after cardi-
ac surgery.91 More research is required to find true effects of ACEI’s in the acute and 
late postoperative setting for the prevention of POAF.8  
Benefits from other prophylactic measures, such as the administration of cortico-
steroids, Colchicin, or vitamin C, are postulated in some reports,92 but lack sufficient 
evidence for standard practice. The use of statins as a prophylactic measure has shown 
conflicting results 8 although a meta-analysis showed significant POAF reduction in 
statin treated arm.93 Intravenous administration of magnesium might reduce the inci-
dence of POAF, although conflicting results on this issue are reported.65 In patients 
without renal dysfunction the probability of adverse effects is very low. In these pa-
tients some 68 but not all guidelines recommend the perioperative use of magnesium. 
Further research on the usefulness, and applicability of these, and other preventive 
strategies is warranted. 
T r e a t m e n t  
In the majority of patients, POAF will spontaneously convert to sinus rhythm within 24 
hours after surgery. Correction of predisposing factors such as hypoxia, anemia, and 
electrolyte imbalance, should be the first step in the management of POAF. The superi-
ority of a certain drug regarding rate control remains to be proven. Therefore the deci-
sion of the drug to be administered should be based on the side effect profile, contrain-
dications, and local familiarity with the drug.94 
In case of hemodynamic instability cardioversion to sinus rhythm by direct current 
(ECV) or pharmacologically with ibutilide or amiodarone, should be pursued. 95 Also if 
patients are highly symptomatic or when rate control is difficult to achieve, electrical 
direct current cardioversion is recommended.8, 54 
Oral anticoagulation 
Since the risk of stroke is increased in patients with POAF,3 starting with oral anticoagu-
lation within 48 hours of the onset of AF, is recommended.8, 54, 68 96 In contrast to pa-
tients with AF in the general population, it has yet to be proven for patients with POAF 
that anticoagulation will decrease the risk of stroke. It is recommended to continue 
anticoagulation for at least 4 weeks after conversion to sinus rhythm,95, 97 although 
convincing evidence is lacking.  
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C o n c l u s i o n s  
The pathophysiology of POAF is not completely understood. In general, AF initiation and 
perpetuation has been attributed to (or a combination of) ectopic focal discharges and 
reentry primarily represented by multiple wavelets.10 In the postoperative setting, it is 
conceivable that in different patients, different mechanisms perpetuate AF. This is re-
flected by the fact that the preventive and therapeutic strategies are only helpful in 
some patients in the early phase after cardiac surgery. In patients with highly diseased 
atrial tissue e.g. due to chronic atrial stretch or advanced age, AF might not only occur 
in the early postoperative phase, but also during the days and weeks thereafter. Indeed, 
data on late POAF is accumulating and shows a potential role for prolonged monitoring 
in high-risk patients.2, 14, 98, 99  
Future research needs to address the incidence of ‘late POAF’ in the weeks and 
months after discharge. It is also of interest how this incidence depends on the heart 
disease and other clinical factors. Finally, the therapeutic implications of ‘late POAF’ 
need to be defined. As a first step towards these objectives more studies systematically 
studying ‘late POAF’ in different indication groups are urgently needed. 
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A b s t r a c t  
Background Postoperative atrial fibrillation (POAF) is considered to be a transient 
arrhythmia in the first week after surgery.  
Object ives The aim of this study was to determine the 30-day incidence and predic-
tors of POAF and the value of postoperative overdrive biatrial pacing in prevention of 
POAF. 
Methods Patients (n=148) without a history of AF undergoing aortic valve replace-
ment (AVR) or coronary artery bypass graft (CABG) were randomized into a pacing 
group (n=75) and a control group. Patients were treated with standardized Sotalol post-
operatively. Rhythm was continuously monitored for 30 days by a trans-telephonic 
event recorder.  
Results  POAF occurred in 73 patients (49.3%) of whom 60 patients (40.5%) showed 
POAF during postoperative days (POD) 0-5 and 37 patients (25%) during POD 6-30. 
Prolonged aortic cross clamp time (ACCT) was an important univariate predictor of 30-
day and of late POAF (POD 6-30) (p=0.017, p= 0.03 respectively). Best-fit model analysis 
using 15 predetermined risk factors for POAF showed different positive interactive ef-
fects for early POAF (i.e. baseline C-reactive protein (CRP) levels with a history of myo-
cardial infarction or low body mass index (BMI)) and late POAF (i.e. high BMI, diabetes 
mellitus, baseline CRP, early POAF, creatinine levels, type of operation, smoking and 
male gender). Biatrial pacing reduced the late POAF incidence in patients with ACCT > 
50 minutes (p=0.006).  
Conclusion POAF is not limited to the first week after cardiac surgery but also occurs 
frequently in the postoperative month. It is desirable to regularly follow POAF patients 
for AF recurrences after discharge. 
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I n t r o d u c t i o n  
Historically, postoperative atrial fibrillation (POAF) has been defined as a transient ar-
rhythmia in the first week after cardiac surgery, with a peak incidence between the 
second and third postoperative days. A growing body of evidence has identified POAF as 
an important risk factor for increased late mortality. 1, 2 Data on the incidence of POAF 
after discontinuation of in-hospital continuous telemetric monitoring are rare but in-
creasingly important because POAF may show later occurrences. 3 
In addition, despite the several treatment and preventive strategies, the reported inci-
dence of POAF remains high. 4, 5 Overdrive atrial pacing has shown conflicting results in 
previous studies when tested for POAF prevention. 6-9 To our knowledge, long-term effects 
of strategies to prevent POAF have not yet been studied. We hypothesize that episodes of 
AF frequently recur after the first postoperative week and aimed to determine the preven-
tive value of synchronized biatrial overdrive pacing on the 30-day POAF incidence.   
M e t h o d s  
Population  
Between October 2009 and July 2011, patients undergoing elective coronary artery 
bypass graft (CABG) or aortic valve replacement (AVR), without a known history of AF or 
any treatment for that purpose were enrolled in the study. Exclusion criteria were a 
history of AF, sick sinus syndrome or AV-block. The local medical ethical committee 
approved this trial. 
Study protocol  
All patients underwent elective CABG or AVR using cardiopulmonary bypass, through a 
median sternotomy, with the use of cold crystalloid antegrade cardioplegic support. Peri-
operatively two pairs of unipolar temporary atrial pacemaker wires (Flexon ™) were placed 
on the epicardium of the right atrial wall and on the Bachmann bundle in all patients (figure 
1). Patients were randomized into a pacing and non-pacing group and all were treated with 
Sotalol during the first postoperative week, unless contraindicated (dosage and discontinu-
ation left to the discretion of the attending resident and the cardiologist).  
The rhythm of patients was monitored by daily review of the continuous telemetric 
monitoring (POD 0-3). Twelve lead ECGs were obtained on the first, second and fourth 
postoperative days. In addition, from the moment of cessation of in-hospital telemetric 
monitoring, continuous trans-telephonic monitoring was started for a total of 4 weeks. 
For this purpose an external one-lead trans-telephonic loop recorder (Vitaphone 3100 
BT ™) with an autotrigger for AF, was used. It detects conversion of sinus rhythm (SR) 
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into AF and AF into SR. Clinical and rhythm-monitoring data were collected and ana-
lysed by blinded investigators. 
 
 
Figure 1.  Schematic representation of the electrode placement. The right atrial (red line) and the Bachmann 
bundle (blue line) wire placement. BB= Bachmann’s bundle; RA= right atrium; LA= left atrium; VCS= superior 
caval vein; VCI= inferior caval vein 
Pacing protocol   
After arrival at the cardiovascular intensive care unit, pacing wires in the pacing group 
were connected to the output of an external pacemaker and pacing protocol was initi-
ated. The sensing and stimulus threshold of all wires were tested prior to chest closure 
and on a daily basis after surgery. The output was set at 2 times greater than the stimu-
lation threshold of the pacing site with the highest threshold (i.e. Bachmann's bundle or 
right atrium). The sensitivity was set at half of the sensing threshold of the location with 
the lowest threshold. Pacing was maintained for 72 hours in AAI mode, 10 beats per 
minute (bpm) above the intrinsic heart rate (minimum of 80 and maximum of 120 
bpm). Pacing was stopped during AF or sinus tachycardia > 110 bpm, and resumed after 
conversion to normal sinus rhythm (SR) to complete the 72-hour protocol. Uni-atrial 
right atrial pacing in the non-pacing group (POD 0) in response to bradycardia was not 
considered a protocol violation (n=7). In case of loss of capture and/or failure of sens-
ing, the anode and cathode connections to the pacemaker were exchanged. The same 
was done when phrenic nerve pacing occurred. All pacemaker wires were removed 
after 72 hours.  
Outcomes   
Atrial fibrillation was defined as an irregular RR interval during at least 10 seconds, 
without a detectable p-wave. 10, 11 The event rate and duration of POAF was compared 
between study groups for early POAF (POD 0-5), late POAF (POD 6-30) and total POAF 
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(POD 0-30). Secondly, we aimed to determine demographic and clinical risk factors 
confounding the net effect of pacing on all outcome measures. 
Statistical analysis   
Metric variables are characterized by means and standard deviations, if they are nor-
mally distributed as tested by the Shapiro-Wilk test. Baseline patient characteristics 
between both randomized groups were tested by the Student t-test (if normally distrib-
uted), the Mann-Whitney test (if not) or the log-likelihood chi-square test (for categori-
cal data). 
Univariate analysis to examine the relationship of risk factors or variables with early 
POAF, late POAF and overall 30 day POAF are provided by means of absolutes and per-
centages, log-likelihood chi-square (χ2L), p-values of χ
2
L, odds ratios (OR) and 95% Confi-
dence Intervals (C.I.) of the OR. Multivariate analysis on the three POAF incidence 
measures (early, late and total POAF) was performed by Cox regression analysis. At first, 
a univariate Cox regression analysis was performed using the experimental groups fac-
tor (non-pacing vs. pacing), in addition to a per protocol analysis for three groups (non-
paced vs. sufficiently paced vs. insufficiently paced). Next, a direct-effects Cox regres-
sion model with only statistically significant effects on each of the three outcome 
measures was searched for by means of the backward elimination log-likelihood chi-
square technique using a predetermined list of 15 risk factors for POAF in addition to 
the experimental factor. All first-order interactive effects of these risk factors between 
themselves and that of each risk factor with the experimental groups factor (nonpacing 
vs pacing) were group-wise and hierarchically tested by backward elimination log-
likelihood chi-square. Finally, for each of the three measures separately a final Cox re-
gression model was searched for containing only statistically significant effects. A p-
value of less than 0.05 was considered to be statistically significant. All types of analysis 
were performed using SPSS-pc version 20.0.   
R e s u l t s   
Patient characteristics  
Of 163 patients who had given informed consent to participate, 15 patients (9.2%) were 
excluded due to surgical complications or difficulty of placement of the Bachmann bun-
dle wires. Patients (n= 148) were followed for an average of 22.26 (± 9.98) days (range 4 
- 42). Protocol violations occurred in the pacing group (i.e. pacing stopped before the 
end of the 72 hour protocol left to the discretion of the attending physician: 48 hours 
pacing n= 6; 24 hour pacing n= 8 and no pacing at all n= 6). Due to its potential pro-
arrhythmic effects Sotalol was discontinued during the early postoperative phase in 55 
patients (37.0 %) by the attending cardiologist. Two patients required amiodarone for 
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persistence of AF and no patients underwent electrical cardioversion. None of the pa-
tients died during the follow-up. Baseline characteristics in both groups were compara-
ble except for COPD and DM. (Table 1)  
Table 1.  Patient characteristics  
 Pacing (n= 75) Non-Pacing (n= 73) p 
Age 66.5y (9.81 44-87) 68.3y (9.14 44-82) P=0.198b 
Male 61(81.3) 59(80.8) P=0.937a 
BMI 26.6 (3.82) 27.8 (3.57) P=0.050c 
LVEF <50% 18(24.0) 15(20.5) P=0.614a 
Hypertension 70(93.3) 67(91.8) P=0.719a 
COPD 2(2.7) 8(11.0) P=0.038a 
Preop β-blocker use 57(76.0) 54(74.0) P=0.776a 
Diabetes Mellitus 14(18.7) 24(32.9) P=0.047a 
History of smoking 23(30.7) 20(27.4) P=0.661a 
Hypercholesterolemia 70(93.3) 68(93.2) P=0.965a 
Myocardial infarction 13(17.3) 14(19.2) P=0.771a 
Creatinine 92.3 (27.44 50-243) 94.1 (24.52 56-194) P=0.525b 
ACCT 49.1 (15.52 25-95) 49.9 (17.52 19-115) P=0.808b 
CABG 66(88.0) 61(83.6) P=0.439a 
Number of anastomoses 3.1(0-6) 2.8(0-5) P=0.141b9 
BMI: body mass index; ACCT: aortic cross clamp time; CABG: coronary artery bypass graft; COPD: chronic 
obstructive pulmonary disease; LVEF: left ventricular ejection fraction. a = Log-likelihood chi-square test , b = 
Mann-Whitney test,  c = Student t-test; Means with standard deviations and minima-maxima in brackets or 
numbers with percentages for both randomized groups. 
POAF incidence  
POAF occurred in 73 patients (49.3%) within the total 30-day follow-up period. The day-
to-day prevalence of AF is shown in figure 2a and stratified by pacing and control group in 
figure 2b. In the early postoperative period (POD 0-5), 40.5% of the patients (n= 60) de-
veloped POAF, while the prevalence was 25.0% (n= 37) in the POD 6- 30. The durations of 
AF episodes during each day were added together and the total time in AF per day (AF 
burden) was calculated. Early POAF caused a larger AF burden (average 32.51 min, 0- 451 
min) compared to late POAF (average 10.6 min, 0- 450 min, p< 0.001). Notably, AF burden 
of early POAF in patients (n= 24) developing additional late POAF was significantly larger 
(63.34 min in early POAF) compared to the AF burden in patients (n= 36) who only had 
early POAF (35.06 min in early POAF, p= 0.013). In thirteen patients (8.8%) the first epi-
sode of AF was detected during POD 6-30 (average duration 13.09 min). 
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Univariate analysis  
In the univariate analysis only aortic cross clamp time (ACCT) was a statistically signifi-
cant predictor of overall POAF (POD 0- 30) (p= 0.01).  We found no significant predictors 
of early POAF. On the other hand, early POAF itself was a strong predictor of late POAF 
(p< 0.001). Also, patients with ACCT> 50min and patients who underwent AVR showed 
significantly higher incidence of late POAF. 
Multivariate analysis 
A high level of baseline CRP combined with a history of myocardial infarction or with low 
BMI was associated with higher chances of getting early POAF (p= 0.030 and p= 0.022 
respectively) (Table 2).  Seven interactive effects and one direct effect were found for the 
prediction of late POAF. In patients with ACCT> 50min, pacing reduced late POAF (p= 
0.006) while it did not in the overall patient population. Pacing in patients with high pre-
operative levels of creatinine (> 129 umol/L) increased the risk of late POAF (p= 0.041). 
These results have been corrected for the remaining 5 interactive effects (Table 3).  
The highest significant interactive effect for prediction of total 30-day POAF was the 
combination of high (> 1.0 mg/L) level of baseline CRP and a history of MI (p= 0.008). In 
addition, a high (> 60min) ACCT (p= 0.017) and smoking tended to be associated with 
overall POAF (p= 0.051) (Table 4). No effects of Sotalol in the prevention of POAF were 
seen in the final models.  
Per protocol analysis 
To determine the true effect of 72 hour pacing on POAF, a per-protocol analysis was 
performed. For this purpose we compared patients who were biatrially paced for a total 
of 72 hours post surgery (n= 52), with the non-pacing group (n= 73). In this approach 
the patients who were insufficiently paced were excluded (n= 23, 15.5%). No significant 
effect of pacing on POAF was seen in this analysis. 
Table 2:  Multivariate analysis for early POAF  
Predictors Ln. Regression S.E. Loss in χ2L p Cox reg 95% C.I. 
BMI 0.086 0.057   1.090 0.974-1.220 
CRP 0.830 0.419   2.293 1.009-5.213 
MI -0.367 0.493   0.693 0.264-1.820 
Pacing 0.013 0.266 0.002 0.961 1.013 0.602-1.706 
BMI*CRP -0.034 0.016 5.217 0.022 0.967 0.937-0.998 
MI*CRP 0.248 0.110 4.708 0.030 1.281 1.033-1.589 
Results of the final, best-fitting Cox-regression model for early POAF (POD 0-5): The model comprises one 
(non-significant) direct effect for Pacing and two interactive effects. n=148. BMI: body mass index; CRP: C-
reactive protein; MI; myocardial infarction; 
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Figure 2a(top).  Daily prevalence of POAF and Figure 2b(bottom) Incidence of POAF as stratified by 
pacing and control group.  
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Table 3.  Multivariate analysis for late POAF 
Predictors Ln. Regression S.E. Loss in χ2 p Cox reg 95%C.I. 
BMI 0.048 0.060   1.050 0.934-1.180 
ACCT 0.038 0.014   1.039 1.010-1.068 
Baseline Creatinine -0.054 0.020   0.947 0.912-0.984 
CABG(0)→AVR(1) 3.736 2.282   0.024 0.000-2.089 
Diabetes Mellitus -18.859 5.060   0.000 0.000-0.000 
Smoking -2.881 2.039   0.056 0.001-3.049 
Baseline CRP -0.382 0.148   0.682 0.510-0.912 
Early POAF 0.441 0.214   1.555 1.022-2.366 
Pacing (0→1) -1.339 1.946   0.262 0.006-1.882 
Gender 2.088 0.760 11.352 0.001 8.068 1.818-5.805 
BMI * DM 0.605 0.159 14.372 <0.001 1.830 1.341-2.498 
ACCT * Pacing -0.061 0.023 7.453 0.006 0.941 0.899-0.984 
Creat* Operation 0.061 0.026 6.083 0.014 1.063 1.011-1.118 
Creat * Smoking 0.040 0.022 3.826 0.050 1.041 0.997-1.087 
DM * early POAF 1.011 0.503 4.210 0.040 2.747 1.025-7.361 
Creat * Pacing 0.035 0.018 4.178 0.041 1.035 1.000-1.072 
CRP * Early POAF 0.132 0.049 6.486 0.011 1.141 1.036-1.256 
Results of the final, best-fitting Cox-regression model for late (6-30 days follow-up) post- operative AF. The 
model comprises one direct effect for Gender and six interactive effects including one involving a specification 
for Pacing. N=148. (Abbreviations as in Tables 1 and 2) 
Table 4.  Multivariate analysis for total 30-day POAF 
Predictors Ln. Reg S.E. Loss in χ2L p Cox reg 95% C.I. 
History of MI -0.891 0.512   0.410 0.150-1.120 
Baseline CRP -0.087 0.042   0.917 0.844-0.995 
Pacing (0-1) -0.052 0.242 0.046 0.829 0.949 0.591-1.524 
ACCT 0.017 0.007 5.658 0.017 1.017 1.003-1.031 
(Ex)smoker (0-1) 0.527 0.264 3.818 0.051 1.694 1.011-2.841 
MI*Baseline CRP 0.325 0.118 7.089 0.007 1.384 1.098-1.744 
Results of the final, best-fitting Cox-regression model for total (0-30 days) follow-up postoperative AF. The 
model comprises one (non-significant) direct effect for Pacing and two interactive effects. N=148. (Abbrevia-
tions as in Tables 1 and 2) 
D i s c u s s i o n  
Previous studies have demonstrated that POAF is associated with an increase in long-
term mortality. 1, 2, 12, 13 This observation suggests that POAF does not only occur during 
the first postoperative days but also in the weeks and months thereafter. If this is the 
case, early discontinuation of oral anticoagulation may have adverse effects. Notably, 
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continuation of warfarin after discharge showed protective effects against long-term 
mortality in one report. 1 
However, information on incidence and prevalence of ‘late’ POAF is very limited. To 
our knowledge, this is the first trial using continuous monitoring to detect late episodes 
of POAF after discharge. We demonstrate that POAF is not transient in the first week, 
but has 25% prevalence between day 6 and day 30 after the operation.  
Early POAF  
We demonstrate an important predictive effect of baseline CRP levels in patients with a 
previous MI and in low BMI patients for early POAF incidence. This is in line with the 
established role of systemic and local inflammation in early POAF. Higher baseline CRP 
levels before cardiac surgery have been hypothesized to start early complement activa-
tion during cardiopulmonary bypass, aggravating the acute postoperative systemic 
inflammation, which may lead to POAF. 14 Local inflammation has shown pro-arrhythmic 
effects in the sterile pericarditis model in dogs, in which sustained atrial flutter was 
inducible. 15 Also in a canine model of direct atrial trauma, activation maps revealed 
inhomogeneous conduction, which was diminished by treatment with methylpredniso-
lone. 16 
Our results are in line with previous findings suggesting a postoperative transient 
pro-arrhythmic environment e.g. due to inflammation, oxidative stress, 17 acute atrial 
stretch due to hemodynamic changes, 18 and high sympathetic activity 19 consequently 
elicits AF in a fairly large population with limited structural heart disease. 10  
Furthermore, we demonstrate that the combination of low BMI with higher baseline 
CRP levels predicts early POAF, while high BMI levels predict late POAF. The vulnerability 
of low BMI patients has been demonstrated by increased short and long term mortality 
in patients undergoing CABG. 20 On the other hand, several pro-arrhythmic electrophys-
iological and mechanical changes in obese patients may contribute to a pro-arrhythmic 
substrate for AF 21 and high BMI has been shown to predict POAF.22 
Late POAF  
Early POAF consisted of longer episodes in patients who later on had additional late 
POAF, compared to patients who developed early POAF only. Also predictors for late 
POAF differed from factors predicting early POAF. Late POAF predictors include renal 
dysfunction (measured by creatinine levels) in smokers or in patients undergoing AVR, 
obesity and DM, early POAF both in combination with DM and high baseline CRP levels 
(>3mg/L) and finally male gender. Although some of the interactions may not have a 
causal effect in the postoperative setting, these morbidities have been identified as risk 
factors for AF in general. 23-26  
Despite the fact that the substrate for POAF is partly caused by the surgery itself, 27 
the similarity in risk factors of late POAF and AF in general suggest common mecha-
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nisms enhancing AF susceptibility in this group of patients. 28 Furthermore several struc-
tural abnormalities which potentially contribute to AF in general, have also been 
demonstrated in POAF patients, e.g. atrial enlargement, 29 fibrosis, 30 heterogeneous 
connexin distribution 31 and myolysis.32    
Pacing in POAF  
Overdrive pacing has been successfully used to treat sick sinus syndrome 33 and parox-
ysmal AF. 34 Biatrial pacing (i.e., 80-100 bpm, during 5 minutes) also produces favorable 
hemodynamic changes and shortens the P-wave duration. 35, 36 In the postoperative 
setting, biatrial overdrive pacing has been hypothesized to reduce dispersion of refrac-
toriness and prevent ectopic activity. 9, 35, 37 Although previous studies showed promis-
ing effects of this strategy in early POAF, 4 their results have not been fully comparable, 
because of differences in pacing protocol and definitions of AF varying between minutes 
35 to hours of AF. 38 Also the pacing sites have not been consistent. In our study, the 
pacing wires were placed on the right atrial free wall and on the Bachmann bundle. 
Some studies used posterior left atrial wall instead of the Bachmann bundle, 9 and the 
right atrial free wall is used in most reports.39 However, the Bachmann bundle is not 
only easily accessible by the surgeon, but also seems to be the preferred site for pacing 
in atrial fibrillation.40, 41 This is partly explained by the anatomical position of the bundle 
as a major pathway between right and left atrium. 42 In addition, biatrial pacing in POAF 
has shown superior results when compared to other pacing modalities (eg. right or left 
atrial pacing alone).39 
In this study, biatrial pacing reduced the risk of late POAF incidence in patients with 
ACCT > 50 minutes, but did not affect early POAF. This effect may be explained by pre-
vention of higher levels of oxidative stress which occur due to atrial ischemia in pro-
longed ACCT.43 The effects of reperfusion injury are carried out beyond the first week 
and may affect late POAF more significantly. However, more research is required to 
address this question.   
Study Limitations  
The incidence of late POAF may be underestimated due to the required patient compli-
ance in Vitaphone 3100 ™ device handling. Despite this limitation, we detected a high 
incidence of POAF after discharge. Known AF predictors such as hypertension, heart 
failure and age had no predictive value in this relatively small study. This is due to a high 
prevalence of hypertension and low prevalence of heart failure in this population (i.e. 
more than 90% of our population had hypertension and less than 4% had an LVEF 
<35%) and low variation in age amongst participants.  
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C o n c l u s i o n s  a n d  c l i n i c a l  i m p l i c a t i o n s  
POAF is not limited to the early postoperative phase, but recurs in some patients at 
least in the first postoperative month. In current clinical practice oral anticoagulation 
(OAC) is often discontinued after conversion of POAF to SR. 24, 44, 45 According to our 
results and previous studies, it is desirable to regularly follow POAF patients for AF re-
currence and treat the high-risk patients accordingly.  
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A b s t r a c t   
Background Postoperative atrial fibrillation (POAF) is a common complication of car-
diac surgery.  While early POAF occurs during the acute postoperative phase, late POAF 
can re-occur in the months thereafter, increasing the risk of stroke and mortality. Given 
the clinical risk profile of cardiac surgery patients, a predisposing structural and electro-
physiological substrate for AF is likely to exist. Using epicardial mapping to determine 
the complexity of AF, we assessed the clinical and electro-pathological profile predicting 
early and late POAF. 
Methods Patients without a history of AF undergoing cardiac surgery were included. 
Prior to cardiopulmonary bypass, electrically induced AF was mapped epicardially using a 
high-density 256-unipolar electrode plaque on the right atrial (RA) wall. Electrophysiolog-
ical parameters such as the number of waves per cycle, fractionation index and break-
through/cycle (BT/cycle) were quantified. P-wave analysis of the preoperative 12-lead 
electrocardiogram was conducted in all patients and correlated to POAF development. 
After surgery, patients were followed for 3 years using a continuous rhythm monitoring 
implantable loop recorder for AF detection and a remote monitoring system. Early POAF 
was defined as AF detected during the first 5 postoperative days, late POAF was defined 
as an irregular RR interval detected on a 2-minute ECG lead between postoperative day 
(POD) 6 until end of follow up. Clinical and electrophysiological data were compared 
between patients developing early and/or late POAF and those without POAF.  
Results All patients (N= 79, 75% male) had hypertension and underwent either coronary 
artery bypass graft (72.2%), aortic valve replacement (22.8%), or mitral valve replacement 
(5.1%), with an average aortic cross clamp time of 60 minutes. POAF occurred in 46 pa-
tients (58.2%); early POAF in 27 patients (34.2%) and late POAF in 37 patients (46.8%), with 
an average duration per episode of 218.6 ±284min vs 91.3 ±173.3min respectively (p 
=0.04). Daily early POAF burden was significantly longer when additional late POAF oc-
curred (370 ±276.9 vs 165.7 ±169.8 min, p=0.05). Age and CHA2DS25VASc score were signif-
icantly higher in POAF patients and early POAF was a predictor of late POAF. P-wave ampli-
tude was significantly lower in patients with early POAF; PQ time was prolonged in late 
POAF and P-wave duration shorter in patients developing both early and late POAF. Multi-
variate analysis of clinical an electrophysiological data revealed age as an independent 
predictor in all POAF and CHA2DS2VASc score as an independent predictor of early POAF. In 
addition, RA volume, RA waves/cycle and age were independent predictors of late POAF. 
Conclusion After cardiac surgery, late POAF recurrences are common, with a higher 
CHA2DS2VASc score, advanced age and RA volume as predictors. Besides, a pre-existing 
electrophysiological substrate predisposes patients to POAF and its recurrences. Pa-
tients with high CHA2DS2VASc score developing early POAF should be followed inten-
sively for late POAF recurrences.  
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I n t r o d u c t i o n  
Postoperative atrial fibrillation (POAF) after cardiac surgery is prevalent in up to 50% of 
patients in the first postoperative days and reoccurs in up to 30% in the following 
year.1,2 Early POAF occurring during the first postoperative days is a predictor of AF after 
discharge, 2-4 and predicts increased late mortality and stroke rate in the months to 
years following the initial operation.5-9 In addition, long-term protective effects of anti-
arrhythmic drugs5 and oral anticoagulation8 in patients developing POAF suggests that 
indeed late POAF recurrences contribute to increased risk of stroke.10 However, data on 
incidence and burden of POAF in the years following cardiac surgery are scarce.  
The clinical risk profile of patients developing POAF includes risk factors such as val-
vular heart disease, coronary artery disease, advanced age, hypertension, and heart 
failure, 11, 12 closely resembling that of AF in the general population.13, 14 Although the 
surgical trauma and the acute postoperative phase contribute to a transient phase of 
prevalent early POAF,15 the predisposing co-morbidities in POAF suggest that atrial 
structural remodelling predisposes to POAF and presumably contribute to its recurrenc-
es on a longer term.10 Direct contact epicardial mapping of the atrial wall is a well-
established technique for assessing the substrate for AF, varying from a low complexity 
of fibrillation patterns in acutely induced AF in normal atria16 to more complex patterns 
with higher number of simultaneous wavelets and breakthrough waves in persistent 
AF.17 The relation between substrate complexity and late POAF incidence is yet un-
known.  
We hypothesized that POAF occurs more frequently in patients with a pre-existing 
substrate, which also predisposes patients to late POAF. We also aimed to determine 
the electrophysiological substrate of early and late POAF assessed by direct contact 
epicardial high-density mapping of the right atrium during cardiac surgery.  
M e t h o d s  
Study population 
Between May 2012 and September 2014, patients without a history of AF, undergoing 
open chest cardiac surgery using cardiopulmonary bypass were included. All available 
electrocardiograms, rhythm monitoring data and data obtained from the general practi-
tioner were reviewed for AF episodes prior to hospitalization. Patients had to be 18 
years of age and able to sign informed consent. Exclusion criteria were sick sinus syn-
drome and AV-block. The local ethical committee approved of this protocol.  
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Epicardial mapping protocol 
Under general anaesthesia, after sternotomy, epicardial atrial pacemaker wires (Flex-
on™) were placed on the right atrial appendage. Atrial fibrillation was induced by atrial 
burst pacing (max 800 beats per minute (bpm) and/or incremental/decremental pacing. 
Induction attempts were stopped in case of hemodynamic instability, or when AF was 
not inducible after 10 minutes of atrial burst pacing. A custom-made high-density 
square electrode array (FlexMEA, Maastricht Instruments BV, Maastricht, The Nether-
lands – 26x26mm, 256 electrodes, electrode diameter 0.1mm and inter-electrode spac-
ing 1.5mm) was used for direct contact epicardial mapping. Unipolar AF electrograms 
were recorded from the right atrial wall using an amplifier (filtering bandwidth 0.1–
400Hz, sampling rate 1kHz). After epicardial mapping was completed, cardiopulmonary 
bypass was initiated. 
All files were analysed using an automated analysis described previously.18 In short, 
electrograms were filtered through a 0.5Hz high-pass filter with cancellation of far-field 
ventricular complexes followed by a probabilistic algorithm detecting steepest negative 
local deflections per electrode, accounting for AFCL distribution. From the local deflec-
tions, waves were constructed using wave conduction likelihood method based on the 
normal distributions of conduction velocity (CV) and conduction deviation. We consid-
ered a CV <20cm/s as conduction block. Non-local deflections were considered farfield 
activity if they were larger than 25% of the median of intrinsic deflections. Fractionation 
index was calculated as the ratio between these large non-intrinsic and intrinsic deflec-
tions.  
ECG P-wave analysis 
The day prior to the operation a 10-second ECG was digitally recorded in all patients 
with a sampling frequency of 250Hz, and analysed in Matlab (The Mathworks, Inc., 
Natick, Massachusetts, United States). The ECGs were filtered using a bandpass filter 1-
100Hz. Parameters used for analysis included: averaged P-wave duration, dispersion, 
area, amplitude and PQ-time. 
AF detection during follow up  
After the operation all patients underwent continuous telemetric monitoring in the 
nursing ward until discharge (minimum 3 days). At least 2 ECGs were recorded during 
the first postoperative week. Following the closure of the sternotomy, a Reveal XTTM 
(Medtronic Minneapolis, MN, USA)19 was inserted at the  left parasternal area. This 
implantable loop recorder (ILR) classifies brady- and tachy-arrhythmias based on a spe-
cific algorithm for detection of irregular RR intervals lasting at least 2 minutes. All pa-
tients received a remote monitoring system (CareLink®) at postoperative day 3 for a 
period of 3 years. Patients were instructed to interrogate the ILR once in two weeks. 
Clinical and Electrophysiological Predictors of ILR Detected Late POAF 
59 
The interrogated episodes were stored in a protected central database (Medtronic 
Minneapolis, MN, USA). Each interrogated event contained episodes that were stored 
between the last session and the current interrogation. Only episodes containing an 
ECG recording were included in the analysis. Events stored as text only were excluded. 
Patients were contacted at 3 months, 1 year and 2 years and at detection of AF epi-
sodes and asked for any symptoms of palpitations, changes in medication or hospitalisa-
tions. Recurrent AF episodes were discussed with the patient’s cardiologist and treat-
ment or initiation of oral anticoagulation was left at the discretion of the cardiologist.   
In this study, early POAF was defined as an irregular RR-interval, without evident P-
waves, detected during the first postoperative days (POD) usually on telemetric moni-
toring or ECG lead. Late POAF was defined as an AF episode detected by the ILR on a 
one lead ECG of at least 2 minutes, between POD 6 until the end of the 3-year follow-up 
period.  
S t a t i s t i c s  
Analysis was performed using SPSS (IBM SPSS statistics version 21.0). Data are ex-
pressed as mean ± SD or percentages. Patients developing POAF at different time points 
were compared to patients without POAF using an unpaired Student's-t-test or analysis 
of variance (ANOVA). For differences between early and late POAF a paired Student's-t-
test was used if normally distributed or Wilcoxon Rank sum test if not. Categorical data 
were analysed using Pearson’s chi-square test. P-values <0.05 were considered statisti-
cally significant. For multivariate analysis we first conducted a univariate logistic regres-
sion analysis of 10 predetermined clinical and electrophysiological variables using total 
POAF, early POAF, late POAF and early AND late POAF as dependent variables. After-
wards we used the variables with p<0.05 in a multivariate logistic regression analysis 
(backward elimination, assessing goodness-of-fit with a Hosmer-Lemeshow test). For 
the multivariate analysis we excluded the electrophysiological data from the epicardial 
mapping (due to loss of power) but conducted a subgroup multivariate analysis includ-
ing these data.  
R e s u l t s   
Clinical data  
Seventy-nine patients were included and received a Reveal XTTM (Medtronic Minneap-
olis, MN, USA) of whom 6 were explanted during follow-up due to pain or infection. 
Patients were on average 65 years of age, all had hypertension, with an average 
CHA2DS2VASc score of 2.4±1.3. In this population 72.2% underwent CABG alone with an 
aortic cross-clamp time of 60±25min. Right atrial volume was on average 52±15.7ml. 
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Pre-operatively, most patients were treated with a beta-blocking agent (72.2%) and 
statins (84.8%) (Table 1). Postoperatively all patients received standardised beta-
blockers for POAF prevention unless contraindicated, although this was left at the dis-
cretion of the treating physicians.  
Table 1:  Basic clinical characteristics 
Clinical parameter N = 79 
Age (years) 65 (±9.0) 
BMI 27.5(±4.5) 
RA-volume (ml) 51.87(±15.68) 
RAVI  
LA-volume (ml) 
25.2 (±8) 
79 (±24.5) 
LAVI 
LVEF 
40.2 (±14.4) 
60%(± 5%) 
Creatinine 90.1(±21.2) 
COPD 11(13.9%) 
HATCH score 1.7(±1.1) 
CHA2DS2 VASc 2.4(±1.3) 
- CHF 10 (12.70%) 
- Hypertension 79 (100%) 
- Age>75/ 65-75 13 (16.46%)/ 23 (29.11%) 
- Diabetes 16 (20.25%) 
- Stroke/TIA 6 (7.59%) 
- Vascular disease 15 (18.99%) 
- Sex 20 female 
CABG 57 (72.2%) 
AVR± CABG 18 (22.8%) 
MVR± CABG 4 (5.1%) 
ACCT 60min (±25) 
ICU-stay (days) 1.5 (±1.6) 
Β-blockers 57(72.2%) 
ACE inhibitors 27(34.2%) 
Statins 67(84.8%) 
BMI=body mass index; RA= right atrium; CABG= coronary artery bypass graft; AVR=aortic valve replacement; 
MVP=mitral valve repair/replacement; LAVI/RAVI=left and right atrial volume index; LVEF= left ventricular 
ejection fraction; CHA2DS2 VASc score = CHF, congestive heart failure/ hypertension/ age/ diabetes/ 
sex/vascular disease; HATCH score= hypertension/ age>75years/ transient ischemic attack (TIA) or stroke/ 
chronic obstructive pulmonary disease (COPD) /heart failure; ACCT=aortic cross clamp time. 
P O A F - p r e v a l e n c e  
During a follow-up of 3 years (range 5 days - 36 months), 3605 device interrogations 
were sent to the Carelink® central database for analysis (mean 48 per patient, range 3-
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150). Forty-six patients (58.2%) developed POAF. Early POAF was detected in 27 pa-
tients (34.2%). Interestingly, two thirds of this group (18 patients, 22.8% of total) had 
additional late POAF episodes. In addition, 19 patients (24.1%) developed only late 
POAF without any early POAF episodes. Nine patients (11.4%) developed only early 
POAF without any late POAF episodes (Table 2). 
Table 2.  POAF incidence n=79(%) 
 late POAF – late POAF + Total  
early POAF – 33 (41.77) 19 (24.05) 52 (65.82) 
early POAF + 9 (11.39) 18 (22.78) 27 (34.18) 
 42 (53.16) 37 (46.84) 79 (100) 
Cross tabulation between early and late POAF. 
 
 
Figure 1.  Prevalence of POAF in the first postoperative month (top left) and the following months excluding 
the first month (bottom left) and the average duration per episode on a logarithmic scale in the first post-
operative month (top right) and the following months (bottom right). POD=postoperative day, POM=post-
operative month. 
 
The temporal variation in POAF incidence is presented in figure 1. As expected, the peak 
incidence of POAF occurred during the first few days after the operation with a notable 
decline after POD 5. However, after this period, there is a steady incidence of 5-10% in 
the following 17 months, slowly declining in the months thereafter, presumably due to 
decreased intensity of rhythm follow-up (inherent memory limitations of ILR, patient 
compliance and loss to follow-up). On the other hand, the average duration per episode 
on a daily basis remained consistent ranging between 10-100 minutes until the end of 
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the follow-up period. On average, the duration per episode in early POAF was longer 
than in late POAF (219 ±284min vs 91±173min, p=0.02) (Figure 2). Daily early POAF 
burden was also significantly longer in patients developing additional late POAF, com-
pared to early POAF only (370±277 vs 166±170 min, p=0.05). In late POAF, 3 patients 
developed >24 hours of AF. Patients were contacted after recurrent late POAF episodes 
were diagnosed with the loop recorder.  
 
 
Figure 2.  Boxplot of average duration of early and late POAF. 
 
Interestingly, as depicted in figures 3a and b, the first episode of AF occurred between 
10-40 weeks up to 100 weeks in 1 patient. Sixteen patients (20%) received oral antico-
agulation by their treating cardiologist. 
 
 
 
Figure 3a.  Kaplan-Meier survival comparison between patients with CHA2DS2VASc score of 0-2 (n=47) and 3-
6(n=32). P=0.002.  
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Figure 3b. Kaplan-Meier survival comparison between patients with Age>65 years (n=40) and <65 
years(n=39). P=0.004.  
 
Clinical characteristics of patients developing POAF   
To assess a potential substrate for AF in POAF patients, we analysed the predisposing 
co-morbidities known to affect AF substrates in the general population. Univariate 
characteristics of different POAF subgroups are presented in table 3.  
Age was consistently higher in all POAF subgroups (in years, 68.3±8.5 vs 60.9±8.3 in 
total POAF; 69.6±9.2 vs 62.9±8.3 for early POAF and 68.7±8.4 vs 62.1±8.8 for late POAF, 
p<0.05 for all). CHA2DS2VASc score was higher in total POAF (2.8±1.4 vs 2.0±1.2, P 
=0.01) and in early POAF (3.2 ±1.4 vs 2.2 ±1.2, p =0.01). In addition, HATCH score was 
also higher in early POAF (2.1±1.1 vs 1.5±1.1, p =0.04). Early POAF itself was a predictor 
of late POAF (p =0.01). In multivariate analysis age remained an independent predictor 
of total POAF, late POAF and of early and late POAF, while CHA2DS2VASc score was the 
only independent predictor of early POAF (Table 4). 
Atrial electrophysiological characteristics of patients developing POAF 
To test the hypothesis that the underlying structural substrate for POAF results from 
atrial conduction disturbances we performed direct contact mapping of electrically 
induced AF in the right atrium. In 9 patients sustained AF was not inducible after com-
pleting the AF induction protocol of incremental and burst pacing during 10 minutes. 
Also epicardial mapping could not be performed in another 17 patients because of 
hemodynamic instability during AF (n=4), for logistic reasons due to changes in opera-
tion time schedule (n=7) or poor quality of the electrograms due to electrical noise 
(n=6).  
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A total of 53 mapping files were obtained from the right atrium ranging between 7 to 45 
seconds. Basic electrophysiological characteristics are presented in table 5. AFCL was 
significantly longer in patients who subsequently developed POAF (181 ±3 vs 166±2, 
p=0.03). In accordance with the pre-existing clinical substrate for POAF, fibrillatory 
propagation in the right atrium was clearly more complex in all POAF groups. 
Univariate analysis is presented in table 3. Patients with POAF showed a significantly 
higher number of RA waves/cycle (POAF 5.0 ±1.4 vs 4.0 ±1.6; early POAF 5.3 ±1.5 vs 4.3 
±1.5; late POAF 5.1 ±1.6 vs 4.2 ±1.4 for patients that did not develop POAF, all p <0.05). 
The preoperative ECG showed significantly smaller P-wave amplitude for the early POAF 
group (0.07 ±0.03 vs 0.08 ±0.02, p =0.03), a prolonged PQ time for late POAF (171.7 
±19.1 vs 160.5 ±18.0 ms, p= 0.01) and a smaller P-wave area (3.0 ±0.8 vs 3.6 ±1.1, p 
=0.04) and amplitude (0.06 ±0.03 vs 0.08 ±0.02, p <0.05) and RAFI (total POAF 2.1 ±1.0 
vs 1.7 ±0.7; early POAF 2.5 ±0.8 vs 1.7 ±0.7; early AND late POAF 2.4 ±0.8 vs 1.8 ±0.8 p 
<0.05 for all comparisons). 
Table 3.  Clinical, electrophysiological and ECG characteristics results of analysis of variance (ANOVA) 
  
POAF– 
(n=33) 
 
POAF+ 
(n=46) 
 
P 
Early 
POAF– 
(n=52) 
Early 
POAF+ 
(n=27) 
 
P 
Late 
POAF– 
(n=42) 
Late  
POAF+ 
(n=37) 
 
P 
E&L  
POAF– 
(n=61) 
E&L 
POAF+ 
(n=18) 
 
P 
BMI 27.91 27.28 0.55 27.62 27.39 0.84 27.40 27.70 0.78 27.32 28.30 0.43 
Age (years) 60.88 68.33 0.00 62.92 69.63 0.00 62.14 68.70 0.01 63.48 71.11 0.00 
AoCCT (min) 60.34 60.22 0.98 58.98 62.70 0.55 58.68 62.03 0.58 58.13 67.39 0.19 
CRP 3.93 3.71 0.87 3.84 3.74 0.94 3.54 4.11 0.67 3.64 4.33 0.67 
CHA2DS2VASC 2.03 2.83 0.01 2.15 3.15 0.00 2.29 2.79 0.14 2.28 3.22 0.01 
HATCH score 1.48 1.89 0.10 1.54 2.07 0.04 1.67 1.78 0.64 1.66 1.94 0.34 
RA volume (ml) 46.46 55.50 0.04 53.19 49.36 0.40 48.18 55.70 0.08 53.38 47.00 0.20 
RA BT/cycle 1.05 1.3 0.18 1.13 1.33 0.31 1.09 1.30 0.24 1.12 1.50 0.12 
RA waves/cycle 4.1 5.0 0.05 4.31 5.30 0.04 4.19 5.06 0.04 4.34 5.62 0.01 
RA FI 1.6 2.2 0.02 1.66 2.53 0.00 1.84 2.02 0.43 1.80 2.40 0.04 
P Duration(ms) 113.58 112.06 0.66 114.00 110.00 0.27 111.33 114.44 0.36 113.39 110.00 0.43 
P dispersion 40.56 40.72 0.97 41.85 38.04 0.50 39.69 41.83 0.67 41.31 37.95 0.59 
PQ-time (ms) 162.71 167.61 0.27 165.57 165.30 0.95 160.45 171.69 0.01 164.77 168.38 0.52 
P area 3.46 3.45 0.95 3.52 3.30 0.40 1.12 0.91 0.43 3.57 2.96 0.04 
P amplitude 0.08 0.08 0.24 0.08 0.07 0.03 0.081 0.083 0.42 0.08 0.06 0.00 
ANOVA of patients developing early POAF, late PAOF, early AND late (E&L) POAF: BMI=body mass index; 
AoCCT=aortic cross clamp time; CRP= C-reactive protein; CHA2DS2 VASc score = congestive heart failure/ 
hypertension/ age/ diabetes/ sex/vascular disease; HATCH score= hypertension/ age>75years/ (TIA) transient 
ischemic attack or stroke/ (COPD) chronic obstructive pulmonary disease/heart failure; RA=right atrium; 
BT=breakthrough wave; FI= fractionation index; LA=left atrium; ECG= electrocardiography; P= P-wave 
 
The number of breakthrough waves (BT) per AFCL (BT/cycle) was not significantly dif-
ferent between these groups but a trend towards more BT with POAF recurrence was 
seen. The substrate complexity parameters remained significantly different between 
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POAF and non-POAF groups in the final multivariate model. In addition to age, RA vol-
ume, and CHA2DS2VASc score, independent predictors for POAF were RA waves/cycle in 
total and for late POAF and RA FI for early POAF.  
Table 4a-d.  Results multivariate logistic regression analysis. 
A. POAF 
(n=46) 
Adjust OR (95%CI) P 
Age 1.11 (1.04 – 1.20) 0.03 
Subgroup analysis   
RA volume 1.10 (1.03-1.18) 0.008 
CHA2DS2VASC 3.38 (1.47-7.75) 0.004 
RA waves/cycle 2.06 (1.09 – 3.90) 0.026 
 
B. Early POAF  
(n=27) 
Adjust OR (95%CI) P 
CHA2DS2VASC 1.80 (1.22 – 2.66) 0.003 
Subgroup analysis   
CHA2DS2VASC 2.19 (1.17 - 4.08) 0.014 
RA-FI 4.17 (1.41 - 12.36) 0.010 
 
C. Late POAF 
(n=37) 
Adjust OR (95%CI) P 
Age 1.10 (1.03 - 1.16) 0.003 
Subgroup analysis   
Age 1.15 (1.03 - 1.30) 0.02 
RA volume 1.08 (1.02 – 1.14) 0.01 
RA waves/cycle 1.88 (1.07 – 3.32) 0.03 
 
D. E&L POAF  
(n=18) 
Adjust OR (95%CI) P 
Age 1.13 (1.04 - 1.22) 0.005 
BMI=body mass index; AoCCT=aortic cross clamp time; CRP= C-reactive protein; CHA2DS2 VASc score = con-
gestive heart failure/ hypertension/ age/ diabetes/ sex/vascular disease; HATCH score= hypertension/ 
age>75years/ (TIA) transient ischemic attack or stroke/ (COPD) chronic obstructive pulmonary disease/heart 
failure; RA=right atrium; BT=breakthrough wave; FI= fractionation index; LA=left atrium; ECG= electrocardiog-
raphy; 
 
By adding the RA waves/cycle to the clinical predictors of late POAF (age, RA volume 
and early POAF) the predictive value of the Receiver Operator Curve- model increased 
from area under the curve of 0.78 to 0.86 (Figure 3).  
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Table 5.  Electrophysiological characteristics of epicardial mapping 
 Mean  
(n=53) 
POAF 
(n=30) 
No-POAF 
(n=23) 
p 
AFCL(ms) 177 (±31) 181 (±30) 166 (±24) 0.05 
CV(m/s) 0.58 (±0.1) 0.57 (±0.1) 0.58 (±0.1) 0.7 
BT/CL 1.1 (±0.6) 1.3 (±0.6) 1.0 (±0.5) 0.09 
RA-FI  1.9 (±0.8) 2.2 (±0.9) 1.6 (±0.7) 0.02 
waves/CL 4.6 (±1.6) 5.0 (±1.5) 4.1 (±1.6) 0.05 
RA= right atrium; AFCL= Atrial fibrillation cycle length; ms= milliseconds; CV= conduction velocity (me-
ters/seconds); BT= breakthrough waves; CL= cycle length; FI=fractionation index. 
D i s c u s s i o n  
Previous reports on incidence of late POAF or the effect of interventions on AF recur-
rences did not exclude patients with a history of paroxysmal AF 7, 20 and focused on 
clinically symptomatic AF, relying on electrocardiogram recordings in patient reporting 
symptoms of AF. 2, 4, 21 However, a high percentage of subclinical AF may exist in high-
risk patients 22 and “snapshot” monitoring strategies are insufficient for quantifying AF 
burden.23 To our knowledge, this is the first prospective study with prolonged continu-
ous rhythm monitoring with ILR, in patients without a clinical history of AF undergoing 
cardiac surgery. We found subclinical late POAF recurrences in 47% of patients during a 
3-year follow-up. In our population, late POAF duration was 1.5 hours per episode on 
average. Atrial high rate episodes (AHRE), lasting minutes to hours, detected by cardiac 
implantable electronic devices have been reported to be associated with an increased 
risk for ischemic stroke in general population.22, 24, 25 The ASSERT trial for example, in-
cluded 2580 patients with hypertension without a history of AF and demonstrated AHRE 
in 35% of patients during continuous rhythm follow-up of 2.5 years.26 As expected, the 
risk of stroke in these patients was higher especially in patients with elevated CHADS2 
score (>2.1).25, 26 In line with this, AHRE in the absence of a history of AF has been asso-
ciated with significantly higher incidence of silent ischemic brain lesions detected on 
computed tomography scans.27 Furthermore, 15 minutes of AF or rapid pacing have 
been shown to increase amounts of platelet activation and thrombin generation com-
pared to sinus rhythm,28 emphasizing the potential prothrombotic effects of short last-
ing episodes of atrial arrhythmias.  
 Hence, there is a significant amount of data supporting oral anticoagulation (OAC) 
treatment in patients with short lasting AF episodes. Of note, a sub-analysis of the AS-
SERT trial recently showed that only episodes of subclinical AF lasting longer than 24 
hours were associated with an increased risk of stroke29 and elevated stroke risk in 
AHRE in different reports may have been driven by longer episodes.25 Patients develop-
ing late POAF in our study had an average CHA2DS2VASc score of 2.8, which is known to 
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go along with an increased risk of stroke also in short lasting AF episodes.30 Still, more 
research is required to determine the risk-benefit ratio of oral anticoagulation in late 
POAF. 
 
 
Figure 3.  Receiver Operator Curve- model of predictors of late POAF. Dashed line: Age, RA volume, early 
POAF, AUC 0.78;  Black line: Age, right atrial volume, early POAF and RA waves/cycle AUC: 0.86 
 
We further determined the underlying clinical and electropathological substrate for 
POAF. In our patient population, a higher CHA2DS2VASc score was an independent pre-
dictor of early POAF and advanced age and large RA volume were independent predic-
tors of late POAF. In addition, others have reported predisposing factors to POAF includ-
ing COPD, obesity, systolic dysfunction, and valvular disease. 7, 11, 31 These co-morbidities 
may contribute to atrial remodelling through fibrosis32 and heterogeneous gap-junction 
protein distribution33 resulting into a structural substrate for AF.34, 35 In line with this, 
patients developing POAF showed more complex propagating properties, including 
higher RA/FI and higher number of RA waves/cycle compared to patients without POAF.  
 The complexity of atrial activation pattern during AF is a reflection of the underlying 
structural substrate for AF.17, 36-38 Also in patients without a history of AF some degree 
of remodelling may already exist as previously demonstrated by Konings et al., in pa-
tients undergoing ablation for Wolf-Parkinson-White (WPW) syndrome.16 Similarly, RA 
local conduction slowing and enhanced AF inducibility were seen in patients without a 
history of AF with RA dilatation as a result of an atrial septal defect 39 or as a result of 
chronic hypertension.40 Patients with persistent AF, on the other hand, show a much 
more complex wave pattern with a high number of simultaneous fibrillation waves and 
high number of breakthrough waves as compared to the WPW patients.17, 38  
These findings alongside our epicardial mapping results suggest that some patients 
without a history of AF may have a predisposition to AF as a result of their underlying 
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co-morbidities. Of note, perioperative characteristics such as aortic cross clamp time 
and ICU stay did not differ in patients developing POAF. Patients developing additional 
late POAF showed significantly higher early POAF burden. This suggests that at least in 
this population, the pre-existing substrate resulted in prolonged early POAF develop-
ment, also predisposing to late POAF that potentially requires rhythm follow-up.  
Considering the pre-existing substrate, POAF can thus be predicted by substrate 
quantification in patients undergoing cardiac surgery. The 12-lead ECG has been shown 
to capture AF complexity and propagation properties of the atria. Previously, specific 
ECG parameters such as P-wave dispersion41 and prolonged P-wave duration on signal 
averaged ECG 42, 43 have been described to predict POAF. Also, the number of peaks 
within the P-wave and the terminal force in lead V1 has been shown to detect patients 
with a history of AF. The P-wave area has been described as a predictor for AF and risk 
of stroke in general population.44 However, these results are not solely based on the 
standardised 12 lead ECG and not all previous studies excluded patients with a history 
of AF including patients with lower left ventricular ejection fraction.41-43 In the current 
study, using the standardised (filtered) preoperative ECGs, we found that P-wave ampli-
tude and P-wave area were significantly lower in patients developing both early and late 
POAF. Although the filtered 12 lead ECG is known to smoothen most irregularities and 
peaks compared to signal averaged high-resolution ECGs,45 these findings are easily 
available on a broad scale. The clinical use of the p-wave analysis for POAF prediction 
will have to be shown in future studies.  
C o n c l u s i o n  
We found that 47% of cardiac surgery patients in our population developed late POAF 
at least once during 3 years of follow-up with an average duration of 1.5 hours per epi-
sode. Advanced age, CHA2DS2VASc score, RA volume and complex epicardial propaga-
tion patterns were important predictors of early and late POAF. Our data indicate that 
patients developing early POAF are likely to have an underlying structural substrate for 
AF, which predisposes them to late POAF recurrences. Because late POAF has been 
related to increased mortality and stroke, patients with high CHA2DS2VASc score devel-
oping early POAF should be followed intensively for late POAF recurrences. Further-
more, due to the existence of a clinical and electro-pathological substrate, predictive 
efforts should be evaluated in the future studies. 12-lead ECG P-wave characteristics 
may help to identify patients at risk for late POAF.  
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S t u d y  l i m i t a t i o n s  
One important limitation in using Reveal XTTM device is the fact that the device has a 
short storage capacity. At the same time, the device has a relatively low specificity and 
positive predictive value for AF detection (85.6% and 79.3% respectively).46 The prob-
lem arises when the device is used for longer periods and AF episodes are overwritten 
by more recent episodes. This limitation, along with the patient dependent interroga-
tion, leads to relatively high false positive episodes and low frequency of device interro-
gations towards the end of follow-up. However, we regularly contacted the patients to 
keep the time between interrogations short and analysed more than 3000 interroga-
tions of the implanted devices with an average of 48 interrogations per patient. Another 
important limitation in this study is the fact that patients did not have continuous 
rhythm monitoring prior to the surgery. Therefore, although all medical records of all 
patients were reviewed, it is plausible that at least some of the patients developing late 
POAF may have had episodes of (asymptomatic) AF prior to surgery.  
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A b s t r a c t   
Background: Recent studies have demonstrated dissociation of electrical activity 
between the subepicardial layer and the endocardial bundle network frequently leading 
to transmural conduction (breakthrough) during experimental and human atrial fibrilla-
tion (AF). However, this phenomenon has not been studied in mathematical models. 
Object ive:  The goal of this study was to assess the effect of epicardial fibrosis on en-
do-epicardial dissociation and breakthroughs during AF.  
Methods:   We developed a 3-dimensional model of the human atria, based on MR 
images and histo-anatomical studies, consisting of a thin epicardial layer and an endo-
cardial bundle network. We studied the effect of fibrosis in the epicardial layer on endo-
epicardial dissociation and breakthrough. The simulation results were validated by sim-
ultaneous endo-epicardial mapping of AF in the right atrium of 4 patients with 
longstanding persistent AF and in 3 patients without a history of AF.  
Results:   In both measured and simulation data, endo-epicardial dissociation occurred 
that frequently resulted in breakthroughs. The AF cycle length, conduction velocity, and 
endo-epicardial dissociation were comparable in the mapping studies and the simula-
tions.  Fibrosis increased the average number of fibrillation waves per cycle. Endo-
epicardial dissociation increased from 28.4±1.52% to 57±2.62% and 60.3±2.87% 
(p<0.05), while breakthroughs increased from 1.16±0.45 to 3.80±1.13 to 8.60±1.75 in 
control, moderate, and severe fibrosis (p<0.05). In both mapping data and simulations 
endo-epicardial dissociation correlated with prevalence of breakthrough.  
Conclusion:  Using a detailed model of human atria, we successfully simulated endo-
epicardial dissociation resulting from increased fibrosis, culminating in breakthroughs, 
which emphasizes the 3-dimensional character of AF in humans. 
Keywords:  Atrial fibrillation, computer models, transmural conduction, endo-
epicardial dissociation, breakthrough waves. 
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1  I n t r o d u c t i o n  
The progression of atrial fibrillation (AF) is mediated by a complex process of ion channel 
remodeling and structural alterations including atrial fibrosis.1 Both processes together 
result in an increase in conduction block in the atrial wall resulting in narrower wave-
fronts and increasing dissociation of electrical activity between the epicardial layer and 
the endocardial bundle network.2-5 Verheule et al. demonstrated that transition from 
persistent to permanent AF in goats is characterized by an increase in endomysial fibro-
sis, particularly in the outer millimeter of the atrial wall, leading to loss of side to side 
connections in the subepicardial layer 6 explaining the decline in the electrical coupling 
between the subepicardial layer and the endocardial bundle network.7 As such, in-
creased fibrosis may contribute to dissociation of electrical activity between these two 
layers (endo-epicardial dissociation of electrical activity) giving rise to transmural propa-
gation in both directions. These transmurally propagating waves become visible as 
“breakthroughs” and add to the overall complexity of fibrillatory conduction, and thereby 
to the stability of AF.8 Endo-epicardial dissociation greatly increases the effective surface 
area available to fibrillation waves to propagate and causes the atrial walls to behave as a 
3-dimensional substrate.8 
While experimental studies have demonstrated a clear association between struc-
tural remodeling, endo-epicardial dissociation of electrical activity, and breakthrough 
incidence, the causal role of endomysial atrial fibrosis for the occurrence of 3-
dimensional conduction is still not clear.4, 6 
We hypothesized that isolated epicardial fibrosis is sufficient to enhance dissociation 
and increase breakthrough incidence. To test this hypothesis, we developed a novel 
highly detailed computer model of the atria, which includes an epicardial layer and an 
endocardial bundle network based on a large variety of human imaging and anatomical 
studies. The epicardial layer had varying wall thickness and two to three sub-layers with 
different fiber orientations depending on the atrial region. 9 To validate the model and 
the observed correlation between endo-epicardial dissociation of electrical activity and 
breakthrough rates, we performed simultaneous endo-epicardial high-density mapping 
in human right atria during cardiac surgery. 
2  M e t h o d s  
2.1 Patient characteristics  
In total 7 patients, 4 with longstanding persistent AF (persAF) and 3 without a history of 
AF (sinus rhythm group, SR), were included. All patients underwent on-pump cardiac 
surgery through median sternotomy at Maastricht University Hospital (MUMC), Maas-
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tricht, The Netherlands. The local medical ethical committee approved this study and 
written informed consent was obtained from each patient. 
Table 1:  Patient characteristics 
Gender BMI Age (years) Operations LA-d(mm) EF(%) Rhythm 
Male 23,5 75 AVR 45 35 persAF 
Female 24 72 MVR 100 50 persAF 
Male 30 66 CABG 69 60 persAF 
Male 26,5 77 AVR 72 30 persAF 
Male 30 71 CABG 37 60 SR 
Male 18,7 70 CABG 28 60 SR 
Male 24,2 60 AVR 40 30 SR 
Pt#= patient number; AVR= aortic valve replacement; MVR= mitral valve replacement; CABG= coronary artery 
bypass graft; LA-d= left atrial diameter in mm; EF= left ventricular ejection fraction; persAF= longstanding 
persistent AF; SR= sinus rhythm. 
2.1.1 Simultaneous Endo-epicardial mapping 
Simultaneous endo-epicardial mapping of the right atrium was performed as described 
previously.8, 10, 11 In short, we developed a tongs-shaped mapping device (Figure 1) with 
both arms ending in a square plaque containing 64 unipolar electrodes (8 × 8; inter-
electrode distance 1.5 mm), directly facing each other when approximated. 
2.2 Computational model of AF 
2.2.1 Anatomical structures in the computer model  
Magnetic resonance imaging (MRI) data of a subject with a normal atrial anatomy was 
used to reconstruct global atrial shape. Endocardium and epicardium were traced man-
ually and combined into a 'myocardial envelope': a closed surface containing the atrial 
myocardium. Anatomical features from detailed anatomical studies were added manu-
ally to the model using Blender (The Blender Foundation, Amsterdam, The Netherlands) 
as a 3D editing tool.12-16 Twenty pectinate muscles (PM) in the right atrial free wall in 
addition to Bachmann’s Bundle (BB), interatrial bundles, and the crista terminalis (CT) 
were added based on published anatomical descriptions.12, 13, 15 
 
 
F igure 1.  The Endo-epicardial electrode, the endocardial arm is designed in a convex end to facilitate inser-
tion into the right atrium of the beating heart. Both arms contain identical plaques of 8 x 8 unipolar electrodes 
exactly opposing each other when approximated. 
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As illustrated in figure 2, the model contained four pulmonary veins, caval veins, left 
and right atrial appendages (LAA and RAA), and a LAA trabecular network, as well as the 
coronary sinus. The BB connected regions between superior caval vein and RAA in the 
right atrium to the superior wall of the left atrium. The coronary sinus (CS) originated in 
the right atrium and extended along the left atrial posterior wall. A number of fiber 
tracts connected the CS to the posterior wall of left atrium. These connections were 
created based on the anatomical study performed by Chauvin et al.14 One to three lay-
ers of fiber orientations were added to the model based on several anatomical studies 
(see supplemental material).12, 13 Comparison with results of a recently published sub-
millimeter diffusion tensor magnetic resonance imaging study showed good agreement 
of the prevailing local fiber orientations in our model with human atria.9  
Fibrosis was simulated by zeroing transversal conductivity in a random selection of 
model elements, while keeping longitudinal conductivity unaltered. It was only intro-
duced in the epicardial layer. Two different degrees of fibrosis (moderate (50%) and 
severe (70%)) were selected, simulated, and compared with no fibrosis (i.e. all adjacent 
elements transversely coupled, control).  
Simulations were performed with the propag-5 software 17, 18 and run on 2560 cores 
of a Cray XE6 supercomputer. Ionic currents and calcium handling for each model node 
was described by the Courtemanche-Ramirez-Nattel model.19 
To exclude possible bias resulting from preferential conduction patterns, caused by 
AF induction at a certain site, ten episodes of AF were initiated at different locations for 
each group (see supplemental materials). 
2.3 Signal processing 
In patients, electrograms lasting 30-75 seconds were recorded at a sampling rate of 
1 kHz using a band-pass filter of 0.5-500 Hz. To detect local activation times, data were 
analyzed using an automated algorithm described in detail previously (see supplemental 
methods).20 In simulations, local activation times were calculated using maxima of posi-
tive deflections in simulated action potentials (APs) for each model node. From the local 
activation times obtained, we calculated the atrial fibrillation cycle length (AFCL) and 
the local conduction velocity (CV). Fibrillation waves were defined as groups of local 
activations surrounded by lines of block as described previously.20 From these data, the 
number of fibrillation waves and the number of breakthroughs in both endocardial and 
epicardial layer were calculated. 
2.4 Calculation of endo-epicardial dissociation of electrical activity 
In human recordings, the electrodes on the epicardial and the endocardial planes were 
directly facing each other, allowing us to quantify activation time differences for each 
opposing electrode pair. 
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To calculate the endo-epicardial activation time differences in simulations, model 
nodes were categorized as epicardial, endocardial or endocardial bundle. We created 
pairs of opposing nodes by finding the nearest epicardial node for each endocardial 
bundle node. In order to obtain data from computer simulations that are comparable 
with the clinical recordings, an array of 64 segments (8 × 8 with inter-segment distance 
of 1.5 mm) was created in the epicardial and endocardial layers. Activation times were 
then obtained from the model node that was nearest to each segment centre.  
 
 
Figure 2.   Anatomical model of the atria used for simulations. A) Posterior view B) Sagittal view. C) Fiber 
orientation in anterior view. D) LA posterior wall fiber orientations. E) Trabeculated network in LAA. F) Tra-
beculated network of 20 pectinate muscles in the right atrium (interior view)  
 
The extracted activation time differences in both clinical and in-silico recordings were 
used to assess the degrees of endo-epicardial dissociation of electrical activity. The 
LAAP Intra atrial 
connections
Right 
pulmonary 
veins
CT
Inferior 
caval vein PM
Bachman Bundle
RAA
A) B)
C)
D)
E) F)
Pectinate 
muscles
Crista 
terminalis
Endo-Epicardial Dissociation and Conduction during AF 
83 
smallest activation time differences of each electrode and either the directly opposing 
electrode or one of the 8 electrodes surrounding the opposing electrode were consid-
ered. For the simulations, quantification was performed using the same algorithm. Endo-
epicardial dissociation was calculated from histograms of endo-epicardial activation time 
differences as previously described by Eckstein et al.10Briefly, two distinct populations of 
activation time differences representing dissociated and non -dissociated activity were 
identified by fitting a two-component Gaussian function (for activation time differences), 
or a Gaussian/uniform mixture distribution (for differences in direction) to the histo-
grams. 10 
 
  
F igure 3.  A) Potential map in LA and RA (control). B) Potential map in LA and RA (severe fibrosis). C) Number 
of waves per cycle in patients recordings (N=4 for persAF patients and N=3 for SR patients). D) Averaged 
number of waves in computer simulations (N=10 for control, Moderate Fibrotic, and Severe Fibrotic groups). 
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Figure 4.  An example of a BT occurrence in the epicardial layer: A) A new wave enters the endocardial layer 
(Red) (A’,B’,C’). The epicardium is not activated (A,B,C). The left panels show the local electrograms. B) Epicar-
dial breakthrough (b) as a result of endo-epicardial dissociation. C) The breakthrough in the epicardial layer 
spreads further in an endo-epicardially synchronized manner. 
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3 .  R e s u l t s    
3.1 Patient characteristics 
Simultaneous high-density endo-epicardial mapping of AF was performed in 4 patients 
with longstanding persistent AF and 3 patients without a history of AF in whom the 
arrhythmia was acutely induced by rapid pacing. Patient characteristics are presented in 
table 1. The left atrial diameter was significantly larger in the AF (P=0.016) than in the 
SR group. We included 13 recordings from the 7 patients, ranging between 30-75 se-
conds (38.34±15.7s).  Conduction velocity was higher in the endocardial plane com-
pared to the epicardium (0.66 ±0.08m/s vs 0.58 ±0.06m/s respectively, p=0.05).  
3.2 Basic AF characteristics in human mapping files and simulations 
Both endocardial and epicardial AFCL were similar in the patient recordings and simula-
tions. The AFCL ranged between 139ms to 261ms in the patients (140.3±6.14 for SR 
patients and 194.3±3.7 in persAF patients). In the simulations AFCL was 145±65ms, 
152±3ms, and 197±13ms in control, moderate, and severe fibrosis, respectively. The 
AFCL in severe fibrosis was significantly longer than in control. Endocardial and epicar-
dial CVs ranged between 50.9cm/s and 74.1cm/s in human recordings (64.2±4.64cm/s 
for SR patients and 67.9±23.38 for persAF patients), compared to 55.3±3.5cm/s, 
49.0±4.68cm/s, and 42.6±1.7cm/s in control, moderately, and severely fibrotic simula-
tions respectively.  
3.3 AF conduction pattern complexity 
We assessed AF conduction pattern complexity, in terms of number of fibrillation waves 
in both human recordings and simulations. In Figure 3A and B, examples of fibrillation 
patterns in a control simulation and a severe fibrosis simulation are depicted. In the 
presence of fibrosis, fibrillation patterns in RA, LA anterior wall, and pulmonary veins 
area were more complex compared to control.  
Quantitative results extracted from 7 patients and 30 simulations are illustrated in 
figure 3C and D. The measured number of waves in both endocardium and epicardium 
in patients corresponded well to each other, with a trend to an increased number of 
waves in persAF patients compared to SR patients. The average number of waves per 
cycle was 2.46±1.11 in SR patients and 3.07±0.91 in persAF patients. The same phe-
nomenon was observed in computational simulations, where the number of waves per 
cycle in the epicardium increased significantly from 2.03±0.34 to 3.34±0.96 and 
3.98±0.51 in control, moderately fibrotic, and severely fibrotic models, respectively.  
Chapter 5 
86 
3.4. Endo-epicardial dissociation in human mapping recordings and simulations 
An example of a breakthrough occurrence in the epicardial layer, using simultaneous 
endo-epicardial recording in a patient, is depicted in figure 4. As illustrated in this figure, 
a fibrillation wave (red) entered the endocardial layer (A’, B’, C’ in panel A) while the 
epicardial layer was not activated (A, B, C). Five milliseconds later, a breakthrough ap-
peared in the epicardial layer (panel B). During the next 30ms the wave spread simulta-
neously in the epi- and endocardial layer (panel C).  An example of directly opposing 
electrograms in the endo- and epicardial planes of human right atrium is illustrated in 
figure 5.  
 
 
Figure 5.  Simultaneous mapping of endo-epicardial layers of human right atrium during AF. Epicardial acti-
vation=dotted line, endocardial activation=dashed line. Depicted are 6 electrograms 3 on each side of the 
atrial wall exactly at the same time and space. While at point A, H and I an almost synchronized activity was 
seen with earlier activation at the endocardial front, in B and C endo- and epicardial activations are out of 
phase.  
 
As shown in this figure, at the beginning of the recording endocardial and epicardial 
deflections occurred simultaneously (A) while 80ms later only the endocardial record-
ings showed steep deflections. It is conceivable that at time point A the deflections in 
the endocardial layer reflected far field potentials from the epicardial layer. From time 
point C onwards the deflections occurred nearly simultaneously again in both layers. 
The same phenomenon was observed in simulated APs where a clear endo-epicardial 
Endo-Epicardial Dissociation and Conduction during AF 
87 
dissociation of electrical activity preceded the breakthroughs, while the endo-epicardial 
electrical activity synchronized after the breakthrough (figure 6).  
 
 
Figure 6.  Simultaneous endocardial and epicardial recorded simulated action potentials during occurrence 
of an epicardial BT. A) An example of a BT and the location of recorded simultaneous endo-epi AP. B) Record-
ed simultaneous endo-epicardial APs at the center of a BT. Black arrows indicates moments of epicardial BTs 
occurrence (electrode A). The dotted line shows the disappearance of endo-epicardial electrical dissociation 
due to the occurrence of the last BT. B) Recorded simultaneous endo-epi AP at a neighboring electrode close 
to the BT occurrence position (electrode B). C) Recorded simultaneous endo-epi AP at an electrode further 
from the BT occurrence position. Green arrow shows the effect of the BT on flipping of endo-epi electrical 
activity dissociation (electrode C). 
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Histograms of activation time differences in a SR and a persistent AF patient are illus-
trated in figure 7A and B. For each electrode, the shortest activation time differences at 
the opposing 9 electrodes were considered. The same calculations were performed in 
the computational studies.  
 
 
Figure 7.  Activation time differences between endo and epicardial layers in patients (upper panels) and 
simulations (lower panels), A) A histogram of  endo-epicardial activation time differences in a SR patient. B) 
Histogram of  endo-epicardial activation time differences in a persAF patient. C) Histogram of  endo-epicardial 
activation time differences in a control simulation. D) Histogram of  endo-epicardial activation time differ-
ences in a severe fibrotic simulation. X-axis depict difference in activation time (ms) and y axis depict number 
of events.  
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Examples of activation time difference histograms in control and simulations with se-
vere fibrotic tissue are depicted in figure 7C and D. Examples of simulated break-
throughs are shown in figure 8. While most breakthroughs occurred at the location of 
endocardial bundles (figure 8A and B), some breakthroughs occurred in areas without 
underlying endocardial bundles (figure 8C), suggesting that isolated epicardial fibrosis is 
sufficient to cause endo-epicardial dissociation even within the thin epicardial surface. 
Figure 8D and E depict the endo-epicardial dissociation in patients and simulations, 
which ranged from 28.4±1.52% to 57±2.62% and 60.3±2.87% in control, moderately 
fibrotic, and severely fibrotic models, respectively. Both in the clinical recordings and in 
the simulations, the degree of endo-epicardial dissociation ranged approximately be-
tween 20% and 80%. In the patients, there was a trend towards more endo-epicardial 
dissociation in the patients with persistent AF. In the simulations, fibrosis clearly in-
creased the degree of endo-epicardial dissociation. 
 Interestingly, the increase in endo-epicardial dissociation of electrical activity was 
associated with an increase in the incidence of breakthroughs both in the patient data 
as well as in the simulations. In simulations, the average number of breakthroughs per 
cycle increased from 1.16±0.45 to 3.80±1.13 and 8.60±1.75 in control, moderately 
fibrotic, and severely fibrotic models, respectively. The calculated numbers of break-
throughs per cycle in all simulation groups were higher than the breakthroughs per 
cycle in patients (figure 8F and G). This is due to the fact that the breakthroughs in pa-
tients’ recordings were calculated only within the recording locations, whereas in simu-
lations the whole atrial surface was considered.  Both in the mapping recordings and in 
the simulations, there was a positive correlation between the average number of break-
throughs per cycle and the degree of endo-epicardial dissociated activity (Pearsons 
correlation r=0.61 and p < 0.05, figure 9A for the patient recordings and r=0.72, p < 0.05 
for the simulations). In the simulations, this correlation was partly driven by the differ-
ences between normal and fibrotic groups and partly driven by the differences within 
the 3 groups (r1 = 0.61, p<0.05 and r2 = 0.5, p<0.05 ). 
4 .  D i s c u s s i o n   
To the best of our knowledge, this is the first realistic atrial model that can simulate 
three-dimensional electropathological changes including endo-epicardial dissociation 
and transmural conduction, closely resembling the human 3D substrate for AF. To im-
plement endo-epicardial dissociation of electrical activity and transmural conduction in 
a realistic computer model of AF, we developed a highly detailed 3D anatomical model 
of the human atria.  
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Figure 8.  Examples of BTs. A) in control simulation. B) severe fibrosis. C) slight fibrosis. D) Endo-epicardial 
dissociation (EED) in clinical recordings. E) Endo-epicardial dissociation in simulations. F) Number of BTs per 
cycle in human recordings. G) Number of BTs per cycle in simulations. 
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Our results derived from the new computer model resembled well the basic electro-
physiological characteristics obtained from simultaneous endo-epicardial recordings in 
humans. Parameters such as AFCL, CV, and degree of endo-epicardial dissociation were 
very similar in the model as compared to the AF recordings. Importantly, the introduc-
tion of isolated atrial fibrosis in the epicardial layer resulted in an increase in endo-
epicardial dissociation of electrical activity and the incidence of breakthrough. Addition-
ally, breakthroughs and endo-epicardial dissociation of electrical activity showed a good 
correlation in both patients and simulations. In simulations as well as in patients’ re-
cordings, breakthroughs made a significant contribution to AF complexity. These find-
ings confirm the importance of the 3D electrophysiological substrate contributing to AF 
perpetuation.  
 
 
 
Figure 9.  A)(Left) Correlation between EED and breakthrough incidence in patient recordings. Pearsons 
correlation r=0,61 for both endo and epicardial BT, p<0,05. B) (Right) Correlation between EED and break-
through incidence in simulations. Pearsons correlation r=0,72 and p < 0.05. 
 
4.1. Comparison to other computer models 
Numerous modeling studies have been performed to understand the mechanisms un-
derlying AF.  Models developed for this purpose can be divided into two categories with 
respect to geometrical properties. The first category consists of surface models, which 
treat the atria as a two-dimensional sheet folded into the shape of the atria.21-23 Models 
in the second category are volumetric models that incorporate a greater degree of 
detail on regional variation in wall thickness and fiber orientation.24-29 Models of both 
categories have provided valuable insights into AF mechanisms and perpetuation such 
as ectopy24, AP heterogeneity28, 30 and fibrosis31. A few studies have investigated the 
effect of atrial anatomy, wall thicknesses, and endocardial bundles (modelled by higher 
local wall thickness) on fibrillatory patterns and AF maintenance.24, 29, 30 Recently, Lab-
arthe et al. investigated the effect of transmural heterogeneities on the complex mech-
anisms involved during electrical propagation in the atria using a bilayer atrial model.32 
However, by design, none of these models showed transmural conduction of fibrillation 
waves driven by endo-epicardial dissociation of electrical activity. The novelty of our 
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model is that, due to the presence of the above-mentioned details, it allows us to inves-
tigate this phenomenon, and to assess the effect of structural remodeling in this con-
text.  
The global anatomy in our model was based on MRI data from a human subject with 
normal atrial anatomy. Many anatomical details of the atrial bundle structures such as 
PMs, BB, CT, posterior bundles connecting left and right atrium, CS, and bundles run-
ning beneath the LAA were added to this global anatomy based on anatomical and 
histological observations.12, 30 Furthermore, to investigate mechanisms that contribute 
to AF perpetuation more precisely, a higher level of anatomical detail, such as fiber 
orientation, must be integrated in the model.13, 30 Indeed, the integrated fiber orienta-
tion in this model was also based on histological studies.9, 12, 13, 33 Importantly, based on 
submillimeter diffusion tensor MRI, Pashakhanloo et al. reported that the main features 
of fiber orientations were well preserved among subjects .9 The preferential fiber direc-
tions described in this study are well reflected by our 3D model. All above-mentioned 
properties, included in this model, have been observed as factors determining the 
propagation of fibrillation waves.30  
4.2. The importance of endo-epicardial dissociation in AF  
The mechanisms underlying AF have complex dynamics and involve tight interactions 
across multiple temporal and spatial scales.34 Electrical remodeling, which occurs in the 
very early stages of AF, facilitates the progression from paroxysmal to permanent AF. 
This progression is also associated with irreversible structural remodeling such as loss of 
electrical side-to-side connections due to fibrosis.8 Verheule et al. showed that AF-
induced structural remodeling in the goat is characterized by an increase in endomysial 
fibrosis exclusively in the epicardial layer of the atrium.6 This loss of connectivity can 
also occur between endocardial bundle networks and the epicardial layer. Therefore, it 
leads to endo-epicardial electrical dissociation, which is a prerequisite for transmural 
conduction.8, 10, 35  
 Endo-epicardial dissociation of electrical activity has previously been described by 
Schuessler et al. in isolated canine right atria using simultaneous endo-epicardial map-
ping.36 More recently, optical mapping in isolated right atrial walls from explanted hu-
man hearts showed that intramural micro-reentry circuits may drive AF.37 Gutbrod et 
al., in line with our findings in the goat model 7, 10, showed clear evidence of endo-
epicardial dissociated activity and breakthrough waves in left atria in sheep, also using 
optical mapping.38 De Groot et al. confirmed this with direct contact endo-epicardial 
mapping in human right atria during cardiac surgery, with 65% of breakthrough waves 
explained by activation on the opposing layer.5 This is in good agreement with our find-
ings in human right atrium where a higher degree of endo-epicardial dissociation was 
correlated with a larger number of breakthrough waves resulting in a 3D conduction 
pattern and enhanced overall complexity of AF.8 
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5 .  S t u d y  L i m i t a t i o n s  
First of all, our clinical mapping data were restricted to the right atrial free wall, largely 
because of safety reasons. In the goat model, however, we did not observe qualitative 
differences in endo-epicardial dissociation of electrical activity between right and left 
atria and the data in this study were just used to demonstrate that the data provided by 
the model are quantitatively comparable to the situation in patients. Secondly, we did 
not implement ectopic focal discharges as drivers for AF. A previous modeling study of 
our group has, however, shown that the quantitative relation between endo-epicardial 
dissociation of electrical activity and breakthrough rate does not critically depend on 
whether AF is driven by reentrant mechanisms or by ectopic focal discharges.39 Finally, 
simultaneous endo-epicardial mapping would be desirable in a larger number of pa-
tients to establish differences in the degree of endo-epicardial dissociation between 
patients with and without a history of AF.  
6 .  C o n c l u s i o n  
We created a novel computer model for AF by implementing an epicardial layer and 
endocardial bundle network with realistic assumptions on fiber directions based on 
histological studies and recent MRI studies on the submillimeter level. Simultaneous 
high-density endo-epicardial mapping in patients with AF confirmed the validity of the 
main quantitative characteristics of AF and endo-epicardial dissociation during AF in this 
model. Modeling results showed that isolated epicardial fibrosis is sufficient to explain 
increasing endo-epicardial dissociation of electrical activity and breakthrough incidence 
in complex substrate for AF.  
7 .  C l i n i c a l  R e l e v a n c e  
Our findings may have major clinical implications for the interpretation of mapping 
results to identify targets for AF ablation. Our study demonstrates that conduction pat-
terns recorded on the epicardial or endocardial surface of the atrium does not neces-
sarily reflect the overall conduction pattern in the atrial wall. Also, future computer 
models of AF will have to account for endo-epicardial dissociation and conduction, par-
ticularly when mechanisms of AF are addressed or when used for estimation of efficacy 
of individualized therapy. 
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S u p p l e m e n t a l  m a t e r i a l  
1. Simultaneous Endo-epicardial mapping in the patients 
During cardiac surgery, prior to the insertion of the venous cannula in the right atrium, 
the endocardial arm of the tongs-electrode was introduced into a purse-string suture.  
In patients in SR, AF was induced through burst pacing by epicardial pacing wires. 
When AF was achieved and maintained for 30 seconds, the arms of the electrode were 
approximated to both sides of the atrial wall and a recording was started. By design, the 
electrodes were parallel at 3 mm distance. However, the surgeon could adjust the dis-
tance depending on the quality and amplitude of the electrogram signals.  
2. Local activation detection in patient recordings 
To detect local activation time we used automated algorithms described previously. (1) 
In this method, local deflections are detected after filtering out baseline drift and can-
cellation of ventricular far fields. Negative deflections in the electrograms were detect-
ed using a template matching procedure. Deflections representing local activations 
were identified by optimizing the match of the obtained intervals to the AF cycle length 
probability density function using a probabilistic algorithm as described previously. (1)  
3. Fiber orientations in the developed atrial model 
In the editing software, splines were drawn to define fibre orientations in different 
regions of the atrium. For the left atrial wall, two sets of splines were used to confer 
different fibre orientations on the endocardial and epicardial half of the wall. Each 
model element took its orientation from the nearest spline. In the right atrial wall the 
orientation was governed by the nearest endocardial bundle, and was made perpendic-
ular to it, but parallel to the epicardial surface. An additional set of splines was used to 
confer a circumferential fiber orientation in the pulmonary and caval vein ostia. Endo-
cardial bundles in the RA wall and LAA received a fiber orientation aligning with the 
bundle. The bundles consisted of myocardium to which different conduction properties 
could be assigned. One to three layers of fibre orientations were added to the model 
based on several anatomical studies. (2, 3)  
4. Electrophysiological model for the simulations 
Simulations were performed with the propag-5 software (6, 7) and run on 2560 cores of 
a Cray XE6 supercomputer. Electrical activity was simulated with a mono-domain reac-
tion-diffusion equation. Simulations were performed using an atrial model at 0.2mm 
resolution. Within the myocardial envelope, a 1mm layer of myocardium was placed to 
represent the thin right atrial wall. A 3mm layer was used for the thicker left atrium.  
Ionic currents and calcium handling for each model node was described by the Cour-
temanche-Ramirez-Nattel model.(8) To reproduce electrical remodelling as observed in 
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atrial fibrillation, conductivities for Ito, IcaL, and Ik1 were set at 40%, 35%, and 200% of 
their normal values respectively. (9) 
5. AF initiation 
To initiate AF, a single pacing site in combination with an associated temporary block 
line was used (Figure 1). Ten episodes of AF were initiated at different locations for each 
group.  
 
Figure S2. AF initiation. A) An Example of a spiral wave initiation. Pacing point (black star) and temporary 
line of block (green line). B) Initiated spiral wave (black asteriks) and its trajectory (black arrow). C) Potential 
map at right atrial free wall.  D) Potential map at anterior view.  
6. Detection of Waves in simulations 
A wave was defined as a contiguous area in which all nodes have trans-membrane volt-
ages above a threshold of –60mV. The number of waves was calculated at each milli-
second of simulated time.  
7. Detection of Breakthroughs in the simulations 
A breakthrough (BT) was defined as a wave that appears in the epicardial layer or the 
endocardial bundle network and cannot be related to the propagation of other waves in 
that layer. To detect BTs, wave sizes at each time step were calculated. If a wave smaller 
than a threshold (9 nodes in this study) appeared within the opposing layer and this 
wave had an overlap with a wave in endocardial layer, this was considered as a BT can-
didate. Each BT candidate was monitored and if its size increased in twofold, it was 
confirmed as a BT. 
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8. Statistics  
All human data are expressed as means with standard errors (±SE). We used a mixed 
model analysis (SPSS 20.0) to test for differences between wave characteristics in the 
endo- and epicardial planes in AF and SR groups.  
For the 3D model, all statistical analyses were performed using SPSS software (IBM 
Corp. Released 2013). Statistical tests were performed to compare the 3 groups of 
simulations (control, moderate, and severe fibrosis). The average number of waves, 
breakthroughs, and EED percentage during the whole simulation period were calculated 
for each individual simulation. The results of the 3 groups were compared using one-
way ANOVA with a Bonferroni correction.  
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A b s t r a c t  
Aims: Mapping and interpretation of wave conduction patterns recorded during simul-
taneous mapping of the electrical activity on both endocardial and epicardial surfaces is 
challenging because of the difficulty of reconstruction of reciprocal alignment of elec-
trodes in space. Here, we suggest a method to overcome this difficulty using a concept 
of maximized endo-epicardial phase coherence. 
Methods:  Endo-epicardial mapping was performed in six humans during induced atrial 
fibrillation (AF) in right atria using two sets of 8x8 electrode plaques. For each electrode, 
mean phase coherence (MPC) with all electrodes on the opposite side of the atrial wall 
was calculated. Localization error was defined as a distance between the directly oppos-
ing electrode and the electrode with the maximal MPC.  
Results:  Overall, there was a linear correlation between MPC and distance between 
electrodes with R2=0.34. Localization error obtained for electrodes of the plaque in 6 
patients resulted in a mean 2.3±1.9 mm for 25 s electrogram segment length. 84% of 
the measurements resulted in error smaller than 3.4mm. The duration of the recording 
used to compute MPC was negatively correlated with localization error, however the 
effect reached plateau for segment durations longer than 15 s.   
Conclusion:  Application of the concept of maximized endo-epicardial phase coher-
ence to electrograms during AF allows reconstruction of reciprocal alignment of the 
electrodes on the opposite side of the atrial wall. This approach may be especially use-
ful in settings where the spatial position of endo- and epicardial electrodes for intracar-
diac mapping cannot otherwise be determined. 
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W h a t ' s  n e w ?  
  Phase coherence between electrograms recorded during AF decays with a distance 
between electrodes. 
  This property may be used to localize the closest electrode to an electrode with 
known position by calculating its coherence with remaining electrodes and locating 
the position of maximum coherence. 
  This technique may also be used to localize an electrode with respect to a set of 
electrodes with known positions by calculation of the relative distances between the 
electrodes by using phase coherence as a surrogate distance parameter. 
  Localization of an electrode located on other side of the atrial wall in RA during AF 
can be achieved with a mean error of 2.3±1.9 mm (recording length at least 25 sec). 
  The duration of AF recordings should be at least 15s to minimize localization error.  
I n t r o d u c t i o n  
Despite decades of intense research efforts, detailed mechanism of Atrial Fibrillation 
(AF) initiation, perpetuation and termination remain unclear 1. Most of the findings 
revealing patterns of wave conduction perpetuating AF regard atrial wall as a two di-
mensional medium, measuring electrical activity either on epicardial or endocardial 
surface of the chamber. However, complexity of atrial architecture augmented by struc-
tural remodeling of the atrial wall has been demonstrated to cause dissociation of elec-
trical activity between endocardial bundle network and epicardial layer 2-7. This three-
dimensional complexity of electrical activity during AF requires development of novel 
methods of mapping and wave conduction analysis. 
Simultaneous mapping of endocardial and epicardial electrical activity was already 
achieved in experimental setting using epicardial plaques of electrodes along with intra-
atrial balloon arrays 4 or 'clamp like' devices comprising two plaques of electrodes for 
mapping of both surfaces of the atria 3. The latter solution enables mapping of the wave 
conduction on both epicardial and endocardial surface providing information about 
relative spatial position of the electrodes on both sides of the atrial wall. However, re-
quirement of the incision in order to introduce the clamp limits its experimental utility. 
The former approach doesn't require an incision of the atrial wall for mapping, however 
is limited with respect to positioning of the electrodes (location of the electrodes of the 
intracardiac array with respect to electrodes of epicardial plaques). This limitation 
makes assessment of the endo-epicardial dissociation and interpretation of the wave 
conduction patterns challenging. Exact spatial positioning of the electrodes could be 
achieved using impedance-based three-dimensional anatomical mapping systems, 
however their effectiveness may be limited in open chest experiment due to exposure 
of the heart hampering impedance measurement. Here, we suggest a simple method to 
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reconstruct reciprocal spatial alignment of the electrodes during AF using a concept of 
maximized endo-epicardial phase coherence 8.  
M e t h o d s  
Data acquisition  
Electrical activity of endocardial and epicardial surface of atria was recorded using clamp-
like mapping tool (see Figure 1). The device has two jaws ending in a square plaque 
(1.5x1.5 cm) carrying 64 (8x8) unipolar electrodes that directly oppose each other when 
the device is closed. Using this device, we conducted simultaneous endo-epicardial map-
ping of the right atrial wall in 6 patients with persistent AF undergoing open chest sur-
gery. Prior to the insertion of the venous cannula for the cardiopulmonary bypass in the 
right atrial appendage, the endocardial jaw of the electrode was introduced into the 
purse-string suture that was placed for the venous cannula. By design, the electrode 
arrays were parallel to each other at a 3 mm distance between the arrays. However, the 
surgeon was able to adjust the distance guided by the quality and amplitude of the elec-
trograms. In the beating heart, a 25-second endo-epicardial recording was made before 
the electrode was extracted and the venous cannula was inserted for cardiopulmonary 
bypass. Unipolar electrograms were recorded at 1kHz sampling rate, band-pass filtered 
between 0.1 and 500Hz, digitized and stored for off-line analysis. 
 
 
Figure 1 Clamp-like mapping device used in the study to simultaneously map both endocardial and epicardi-
al electrical activity of the atria during AF. 
Calculation of electrograms phase 
Electrograms phase of was obtained using a concept of sinusoidal recomposition (see 
online Appendix A) followed by Hilbert transform. Phase of the electrogram was defined 
as: 
  (1) 
where u(t) is recomposed electrogram and H(u)(t) is a recomposed electrogram after 
application of Hilbert transform. 
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Assessment of coherence of two electrograms using a concept of mean phase 
coherence  
Mean phase coherence (MPC) 8 between an electrogram at position (i,j) on endocardial 
surface and electrogram at position (m,n) on epicardial surfaces was defined as: 
  (2) 
where t is a time index, T is a number of time samples of the electrogram, φi,j
Endo(t) is a 
phase of the electrogram on endocardial surface and φm,n
Epi(t) is a phase of the corre-
sponding electrode on epicardial surface. In a case both electrograms have identical 
phase in time, MPC is equal to one. In case of uncorrelated electrical activity between 
electrograms, MPC will be close to zero 8. Schematic and an example of mean phase 
coherence (MPC) calculation are shown in Figure 5. 
 
 
Figure 2 Schematic and an example of MPC calculation. Electrograms with corresponding phases recorded 
on endocardium and epicardium (A). For each timepoint, a unit vector with orientation set by phase differ-
ence between both signals is added in the complex plane plot (B) (Δϕ denotes the phase difference between 
electrograms at a given timepoint). Such constructed curve for 4 s of example electrogram (C). Mean phase 
coherence is defined as a distance (denoted as L) between starting point of the curve (0, 0) and an endpoint 
divided by a number of time samples (D). Such defined parameter ranges from 0 if the endpoint is at the same 
location as a starting point, to 1 in case all contributing vectors are aligned along straight line (which corre-
sponds with a constant phase difference) 
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Determination of the electrode position based on mean phase coherence 
For each electrode of the plaque, MPC was calculated between an electrogram of given 
electrode and all electrograms recorded at electrodes on the opposite surface. Position-
ing error was defined as a distance between actual position of the electrode within a 
plaque and the position of the maximum in obtained distribution of MPC values (see 
Figure 3.a). 
 
 
Figure 3 (A): Spatial distribution of mean phase coherence between arbitrarily selected electrode on endo-
cardial plaque (marked as C). Each square corresponds with a measurement electrode. MPC decays with a 
distance from reference electrode C. Maximum of the MPC on epicardial plaque and projection of the elec-
trode C marked with white circles. A distance between position of the maximum and position of the projected 
electrode is interpreted as a measurement error. (B): MPC value as a function of distance from electrode 
calculated or all pairs of electrodes for all patients (N=48140 electrode pairs). Despite significant spread of 
values (error bars denote one standard deviation) MPC exhibits a decay with increasing distance between 
electrodes. 
R e s u l t s  
In order to assess relationship between MPC and a distance between electrodes, MPC 
was calculated between all pairs of the electrodes within the plaque (with electrode 
pairs belonging to either endocardial or epicardial plaque). Combined result for all pa-
tients (N=48140 pairs of electrodes) and length of the analyzed electrogram segment 25 
sec is shown in Figure 3.b. Overall, there was a linear correlation between MPC and the 
distance between electrodes with R2=0.34.  
Mean localization error at an electrode (see Figure 3.a for definition) was defined as 
the distance between the electrode with the maximum endo-apicardial mean phase 
coherence and the directly opposing electrode. The result for each patient is shown in 
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Figure 4.a (result for analyzed electrogram segment length 25 sec). The mean error 
varied between patients with lowest for patient #5 with ε=1.2±1.1 mm and highest for 
patient #6 with ε=3.8±2.0 mm. On average, the localization error was 2.3±1.9 mm.  
The duration of the electrogram used to compute MPC was negatively correlated 
with localization error (see Figure 4.b). However, the effect reached plateau for seg-
ment lengths longer than 15 s. 
 
 
Figure 4 (A): Electrode localization error (a distance between position of reference electrode and a maxi-
mum MPC on the other side of the atrial wall) for all 6 patients included in this study and electrogram seg-
ment length 25 sec. (B): Electrode localization error for various lengths of the  analyzed electrograms seg-
ment.  
 
 
F igure 5 (A): Histogram of localization error ε. (B): cumulative frequency of the localization error ε falling 
within a circles of specified radius with respect to reference electrode. In 21% percent of cases, ε was be-
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tween 0-1.5 mm, in 52% of cases ε was between 0-2.1 mm, etc. Results for analyzed electrogram segment 
duration 25 s. 
The histogram of localization error ε for all patients combined is shown in Figure 5.a. 
Majority of the measurements were related with error ε<5 mm. A schematic presenting 
cumulative frequency of the localization error ε falling within a circles of specified radius 
with respect to reference electrode is shown in Figure 5.b. 84% of the measurements 
resulted in error smaller than 3.4 mm. 
D i s c u s s i o n  a n d  c o n c l u s i o n s   
The main findings of the study may be summarized as follows: 
  Phase coherence between electrograms recorded during AF decays with a distance 
between electrodes (see Figure 3.b). 
  This property may be used to localize the closest electrode to an electrode with 
known position by calculating its coherence with remaining electrodes and locating 
the position of maximum coherence. 
  This technique may also be used to localize an electrode with respect to a set of 
electrodes with known positions by calculation of the relative distances between the 
electrodes by using phase coherence as a surrogate distance parameter. 
  Localization of an electrode located on other side of the atrial wall in RA during AF 
can be achieved with a mean error of 2.3±1.9 mm (recording length at least 25 sec). 
  The duration of AF recordings should be at least 15 s to minimize localization error.  
 
The presented technique may be particularly useful during detailed contact mapping of 
the atrial electrical activity with plaques of electrodes covering the epicardial surface, 
and arrays of the intracardiac electrodes covering endocardial surface (such as de-
scribed in 4). This configuration might be used in an experimental setting in which endo-
epicardial dissociation and conduction is investigated. Also, during endo-epicardial ap-
proaches for AF ablation in hybrid electrophysiology labs this technique might prove 
useful to merge electrograms recording data sets recorded from various arrays of elec-
trodes. These procedures require an open chest or at least a minimal invasive epicardial 
approach, making usage of 3D mapping systems or fluoroscopy to localize the elec-
trodes difficult 9. We suggest, in such setting, application of the proposed method to 
localize electrodes of the intracardiac catheter with respect to epicardial plaques of 
electrodes. Thus, for each electrode of the intracardiac catheter, the closest corre-
sponding electrode of epicardial plaques will be located enabling proper spatial mutual 
positioning of the endocardial and epicardial electrodes. The relative distances between 
electrodes determined from the relative differences in phase coherence may further 
facilitate electrode alignment.  
Assessment of Spatial Alignment of Electrodes During Endo-Epicardial Mapping 
111 
Since proposed method is based on the decay of electrogram phase coherence with 
distance between electrodes, robust results may only be achieved in case of irregular 
atrial activity. Organized arrhythmia (such as atrial flutter) may result in lack of relation-
ship between coherence and distance thus rendering the method inapplicable.  
L i m i t a t i o n s  
This study has following limitations: (i) due to difficulty in obtaining simultaneous endo-
epicardial, high density recordings in human atria, electrograms were recorded only in 
one location in right atria. Measurements at different locations may have yield different 
coherence decay distributions, due to different myocardial architecture and presence of 
fibrosis, (ii) proposed method works best if intracardiac electrode is located in the area 
below epicardial plaque. In case electrode is located in a location falling into a gap be-
tween two different epicardial plaques, reconstruction of its exact positioning may 
require interpolation using the locations of maximum coherence on both plaques. 
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In the first 3 chapters of this thesis we aimed to determine the long-term incidence of 
postoperative atrial fibrillation (POAF) using prolonged rhythm-monitoring strategies. 
We hypothesized that while the incidence of early POAF peaks during the first post-
operative days following the operation, suggesting an important causative role of acute 
inflammatory or autonomic alterations, late POAF also occurs frequently thereafter and 
might be more dependent on pre-existing organ damage. To exclude confounding elec-
trophysiological effects of AF itself we included patients without a history of AF. We 
found that patients with a specific risk profile show mostly subclinical AF episodes last-
ing up to 1.5 hours per episode in the months to years after surgery. We divided the 
postoperative period into an early and late phase considering enhanced effects of the 
acute postoperative triggers in the first days after surgery. This early phase coincides 
with the hospitalization period of most patients undergoing cardiac surgery, which is 
reflected by the follow-up period in most previous studies on POAF. However, identify-
ing the risk profile and the underlying substrate of late POAF contributes to prediction 
and prevention strategies of these episodes. Thus the presence of an underlying sub-
strate for AF and the possible range of substrate complexity in AF should be thoroughly 
studied (Figure 1). For this purpose, electrophysiological mapping techniques are very 
useful. In Chapters 5 and 6 we carried out an in-depth analysis of the effects of fibrosis 
on the 3-dimensional propagation properties of the atria, which is an important con-
tributor to AF maintenance in diverse AF substrates with different co-morbidities.  
It is important to recognize that there are differences in AF substrates resulting from 
different underlying diseases. We further tested this hypothesis by assessing the elec-
trophysiological characteristics of POAF patients as a reflection of a preexisting atrial 
structural substrate. 
A c u t e  p o s t o p e r a t i v e  t r i g g e r s  f o r  P O A F  
POAF is the most common complication after cardiac surgery, affecting up to 60% of 
patients. To fully understand the high prevalence of POAF, it is very important to con-
sider the multitude of pro-arrhythmic mechanisms after cardiac surgery.  
AF initiation and perpetuation are facilitated by a complex interplay between trig-
gers and an underlying structural substrate.1-3 In other words there are specific pro-
arrhythmic areas in the atria causing focal discharges (triggers), while structural changes 
influencing impulse propagation may perpetuate AF (substrate). While triggers can 
initiate an AF episode, the AF substrate determines the stability and duration of an AF 
episode after initiation. In structurally normal atria, a single trigger is likely to cause only 
a short AF episode, and maintenance of AF requires a high frequency of triggering 
events. In contrast, in atria with extensive structural remodelling, a single ectopic beat 
can initiate an AF episode that does not terminate spontaneously, 4 because it is main-
tained by the AF substrate.  
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Figure 1.  Schematic depiction of the pathophysiology of early and late POAF, effect of co-morbidities on 
development of a structural and electrophysiological substrate (curved arrows) for POAF and the subsequent 
triggers in the acute postoperative phase and later on. DM: diabetes mellitus; CHF: congestive heart failure; 
POAF: postoperative atrial fibrillation; SR: sinus rhythm.  
 
The triggers for AF often originate in specific regions, most notably the muscular sleeves 
of the pulmonary veins, but also the ligament of Marshall, the coronary sinus, and the 
ostia of the caval veins. These regions may have specific pro-arrhythmic characteristics 
(i.e. differences in cellular electrophysiology, autonomic ganglia, overlapping and com-
plex myofiber orientation),1, 5-7 but the mechanism underlying ectopic activity (i.e. trig-
gered activity vs. micro reentry) is not certain. Triggered activity often results from 
calcium (Ca2+) oscillations. Calcium overload or abnormal Ca2+handling causes these 
oscillations, which are mediated by Ca2+-induced-Ca2+ release from the sarcoplasmic 
reticulum and lead to delayed after depolarisations (DADs) after a normal action poten-
tial as a result of activity of the sodium-calcium exchanger (NCX).8 Specific conditions 
increasing the likelihood of these events are enhanced sympathetic activity, tachycardia 
and ischemia.1, 4, 8 Furthermore pericarditis,9 acute atrial stretch and oxidative stress 10 
can all cause abnormalities in Ca2+ handling that may provoke afterdepolarisations.  
As discussed in chapter 2, many of these conditions are present during the acute 
postoperative phase. Common examples include volume overload with increased right 
atrial pressures, which may last for days and sometimes weeks before euvolemia is 
achieved. Other examples are infections, pericardial effusions, systemic inflammation as 
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a result of cardio-pulmonary bypass, possibly leading to hypovolemia, and pro-
arrhythmic inotropic agents such as Dobutamine or Milrinone used to stabilize hemo-
dynamics in the intensive care unit. Hence the first few days after cardiac surgery con-
tain an agglomerate of triggers for AF. Notably, the incidence of arrhythmias after car-
diac surgery attributable to the surgical process or postoperative period is much lower 
for ventricular arrhythmias than for atrial arrhythmias. This may be due to the differ-
ences in ion-channel expression between the atrium and ventricle. Expression of the 
inward rectifier potassium channel IK1 for example, is 5-10 fold higher in the ventricles, 
which makes atrial myocytes more excitable than ventricular myocytes.1  
While during the acute postoperative phase, patients are continuously under medi-
cal supervision, after discharge the effectiveness of medical treatment heavily depends 
on patient compliance. It is plausible that modulators increasing risk for late POAF such 
as heart rate variability and autonomic dysregulation 11 may be enhanced in case of 
non-adherence of the patient to beta-blockers 12, 13 or other antihypertensive and anti-
arrhythmic drugs.  
S u b s t r a t e  f o r  P O A F   
Considering the acute postoperative phase, it is easily conceivable that early POAF may 
occur because the high incidence of triggers acts as 'a stress test' on the underlying AF 
substrate. However, we also demonstrated that POAF is not confined to the acute post-
operative phase and a large number of patients are at risk of developing late POAF after 
discharge from the hospital. In addition, we propose that a pre-existing AF substrate 
predisposes patients to late POAF development. We demonstrated that predictors of 
POAF and late POAF include: obesity and diabetes mellitus (DM), smoking and aortic 
valve disease, male gender, C-reactive protein (CRP) levels combined with myocardial 
infarction (chapter 3), advanced age, higher CHA2DS2VASc (Congestive heart failure 
(CHF), hypertension (HT), age, DM, sex, vascular disease) and HATCH (i.e. HT, age >75 
years, transient ischemic attack/stroke, COPD, and HF) scores and right atrial dilatation 
(chapter 4). We also investigated the pre-existing substrate for POAF by quantifying the 
atrial electrical propagation during AF using direct contact high-density mapping of the 
right atrial wall. To examine the complexity of fibrillation in patients developing POAF, 
we compared our results in chapter 4 to previously published data. Figure 2 illustrates 
the RA waves/cycle/cm2 in patients described in chapter 4 (i.e. patients with co-
morbidities, but no AF history) compared to patients undergoing Wolf-Parkinson-White 
ablation (i.e. no risk factors for AF) and persistent AF.14, 15 As expected, due to several 
co-morbidities, patients undergoing cardiac surgery showed more complex fibrillation 
patterns compared to WPW-patients, also when they did not develop subsequent POAF 
(figure 2).  
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Hence the range of atrial remodelling depends on the underlying co-morbidities. 
Predictors of late POAF are similar to those in AF patients in the general population. The 
Framingham study, following 2090 men and 2641 women without a history of AF, 
showed that independent predictors of AF after 38 years of follow-up were diabetes, 
HT, CHF and valvular disease.16 Accordingly, almost 60% of incident AF in general popu-
lation has been attributed to the same elevated risk factors in addition to obesity and 
smoking.17 Furthermore higher HATCH-scores are associated with an increased risk of 
new onset AF 18 and AF progression.19 Indeed, aggressive management of factors such 
as weight, blood pressure, and lipid management, glycemic control, breathing man-
agement during sleep, smoking and alcohol cessation beneficially affect outcome as 
demonstrated by higher success rates of AF ablation compared to a control group.20  
 
 
Figure 2.  The median number of waves/cycle/cm2 as measured by Allessie et al.15 was 2.3 waves/cm2 in 
WPW patients and 4.5 waves/cm2 in persistent AF patients. In comparison recordings from patients with 
hypertension undergoing cardiac surgery showed a median of 4.1 waves/cm2 in patients who developed POAF 
compared to 3.6 waves/cm2 in those without subsequent POAF (see Chapter 4). 
 
On the structural level, there are important proarrhythmic changes resulting from co-
morbidities. One key structural abnormality demonstrated in different models of AF has 
been increased connective tissue deposition and fibroblast proliferation leading to fi-
brosis. The reaction of the myocardium to stressors such as pressure or volume over-
load and ischemia is mediated through cardiac fibroblast activation, synthesis of extra-
cellular matrix proteins as a protective mechanism which in its turn disrupts electrical 
coupling between myocytes.21 Fibrosis can display several distinct patterns.22 As an 
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adaptive mechanism in response to increased stretch or wall stress due to volume or 
pressure overload, a type of fibrosis occurs that has been named reactive, interstitial or 
endomysial fibrosis, characterized by an increase in extracellular matrix volume sur-
rounding individual myocytes. This type of fibrosis occurs in the absence of increased 
myocyte apoptosis or necrosis. By contrast, replacement fibrosis or scar formation oc-
curs in response to myocyte death. In the ventricular myocardium, the exact distribu-
tion pattern of fibrous tissue strongly determines the impact on conduction.23 Accord-
ingly patients with AF also have enhanced level of both types of fibrosis.21, 24  
Nevertheless the relation between AF and atrial fibrosis remains highly complex and 
non-linear. 25-27 Perpetuation of AF is not solely determined by fibrosis; another structur-
al abnormality that has been recognized in recent studies is fatty infiltration.28 Adipo-
cytes intermingling with myocytes are likely to lead to a disruption of propagation similar 
to fibrous tissue. Many areas of fatty infiltration are also surrounded by fibrous tissue.29 
In addition, adipocytes release factors that can be profibrotic, but can also be protective, 
for example by reducing production of reactive oxygen species in myocytes.30 Finally, 
mechanical stress resulting from pressure overload (concentric) and volume overload 
(eccentric), alongside profibrotic stimuli such as transforming growth factor (TGF)-β and 
macrophage mediated inflammation all contribute to myocyte hypertrophy.31 Myocyte 
hypertrophy may compromise contractile function and become proarrhythmic.32 
However, direct causality of diseases in AF is difficult to prove due to co-existence of 
morbidities, especially in the elderly population. For this purpose, animal models (dis-
cussed below) have been useful, assessing the relation between each disease and the 
specific structural changes at the atrial level.  
'Lone AF'  
'Lone AF', i.e. AF without underlying structural heart disease can be mimicked in animal 
models by rapid atrial pacing (RAP), in which a burst pacemaker stimulates the atria at 
high frequency. The goat model of RAP illustrated the progressive nature of AF, as evi-
denced by the gradual loss of efficacy of anti-arrhythmic drugs33 paralleling observa-
tions in AF patients. During the first hours to days of RAP in goats, electrical remodeling, 
i.e. shortening of effective refractory period (ERP) occurs.34 In the ensuing weeks to 
months, atrial structural remodeling slowly develops including myocyte hypertrophy 
and structural changes35 hallmarked by gradual endomysial fibrosis in the outer epicar-
dial layer of the atria.36 Electrical propagation during AF in this model is characterized by 
multiple simultaneously propagating wavelets. Over time, fibrillation patterns become 
more complex and dissociated, with a larger number of waves. We have previously 
demonstrated that conduction does not only become more dissociated within the epi-
cardial plane 36 but also between the epicardial layer and the underlying endocardial 
trabecular network.37 In the goat model of AF, endo-epicardial dissociation explains a 
majority of breakthrough (BT) events, i.e. waves which suddenly appear on the surface 
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of one layer are conducted transmurally from the opposing layer. An increased inci-
dence of BTs had also been described in patients with longstanding AF.38  
 In chapter 5, we demonstrate with simultaneous epi-endocardial mapping that epi-
endocardial dissociation, leading to BTs, also occurs in patients. Interestingly, while 
there was a clear correlation between transmural electrical uncoupling and increased 
BT, these changes were not observed only in persistent AF patients but also in patients 
without a history of AF. This further underscores the range of atrial structural remodel-
ing resulting from underlying cardiovascular diseases. Notably, previous mathematical 
models of atrial propagation have not been able to replicate this behavior.39, 40 After 
taking the 3-dimensional structure of the atrial wall including fiber orientation into 
account, we present in Chapter 5 a computer model that, for the first time, was able to 
demonstrate endo-epicardial dissociated activation closely related to increased BT with 
enhanced levels of endomysial fibrosis. Indeed, this computer model replicated the 
propagation pattern observed in animal models and our patient population.  
Heart Failure 
Heart failure (HF) is also strongly associated with AF development in patients and 41 
atrial fibrosis is significantly more pronounced in patients with heart failure.42 In a ca-
nine model, Li et al, compared 6-8 week of RAP (with controlled ventricular rate) to CHF 
induced by 5 weeks of rapid ventricular pacing (RVP). They found that in contrast to the 
RAP group, HF led to slow and heterogeneous conduction with pronounced atrial fibro-
sis.43 The pattern of fibrosis in this model suggests replacement fibrosis, and indeed, in 
the first days after the initiation of RVP, a dramatic phase of apoptosis, necrosis and 
inflammatory infiltration was observed. After cessation of ventricular pacing for 5 weeks 
in the same model, although recovery of clinical symptoms of heart failure and hemo-
dynamics occurred, tissue fibrosis remained unchanged with consistently enhanced 
vulnerability to AF.44  
Interestingly, in patients with ventricular hypertrophy and diastolic heart failure due 
to aortic valve stenosis, a similar effect is seen. In these patients, both focal replace-
ment fibrosis (scar) resulting from necrosis as well as cellular hypertrophy and connec-
tive tissue deposition (reactive fibrosis) are present and can be quantified by cardiovas-
cular magnetic resonance.45 However, 1 year after aortic valve surgery, contrary to the 
replacement fibrosis, cellular hypertrophy and diffuse reactive fibrosis regress accom-
panied by functional and structural changes.45 These findings alongside the abovemen-
tioned findings from HF and AF models, suggest that reactive extracellular matrix depo-
sition and myocyte hypertrophy are reversible while fibrosis replacing necrotic tissue 
remains present after treatment, as a potential substrate for AF. 
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Mitral regurgitation and atrial dilatation 
Atrial dilatation without HF is another pro-arrhythmic entity in the pathophysiology of 
AF, which is common to many animal models of AF (e.g. RAP, CHF) and has also been 
examined as a separate factor in several models. In patients with atrial septal defect RA 
dilatation is accompanied by electrophysiological changes such as conduction slowing 
and double potentials in the terminal crest.46 Furthermore, in a canine model of left 
atrial dilatation due to mitral valve avulsion, increased atrial size correlated to AF in-
ducibility and duration with histological findings including chronic inflammation and 
fibrosis.47 These structural changes were not associated with altered conduction during 
pacing at slow rates. However, during extra-stimulation protocols, the dilated LA dis-
played direction-dependent conduction abnormalities that were not observed in the 
non-dilated RA of the same animals, nor in either atrium of a control and RAP compari-
son group.48 Also in a model of AV block without HF in goats, atrial dilatation with local 
conduction disturbances was associated with myocyte hypertrophy. Interestingly no 
fibrosis or Cx re-distribution was found 49, 50 suggesting that in this model fibrosis was 
not a prerequisite for AF perpetuation.  
In both MR and AV block models, atrial effective refractory period (ERP) was pro-
longed, which also contrasts the RAP and HF models described above. To further eluci-
date, Sparks et al. investigated the effects of atrio-ventricular (AV) asynchrony and con-
sequent atrial dilatation in humans.51 They compared patients with implanted pace-
makers who were first paced in VVI mode (ventricular pacing only) for 3 months fol-
lowed by DDD mode (atrio-ventricular pacing) to patients who were paced in DDD 
mode continuously. In line with previous findings, they found that after 3 months of VVI 
pacing, both atria increased in size and showed prolongation of ERP and P-wave dura-
tion.51 All these changes were transient and normalized after 3 months of DDD pacing 
comparable to baseline and the control group.51  
In this thesis, RA volume was an independent predictor of late POAF (chapter 4), 
which may have contributed to a substrate for AF beyond the effects of other predictors 
such as age and CHA2DS2VASc score. Interestingly, an indirect effect from the pericardi-
um may also contribute to the right atrial dilating properties. There is a close correlation 
between the right atrial pressure and pericardial pressure before pericardium is 
opened.52 In this sense, the pericardium is a determinant of RA contractility and stiff-
ness as a response to RV afterload.53 In a rabbit model of passive pericardial constraint, 
increasing atrial volume only resulted in ERP shortening and AF perpetuation when the 
pericardium was removed contrary to when the pericardium was still intact,54 suggest-
ing that atrial stretch as opposed to atrial pressure contributes to vulnerability to AF. 
During cardiac surgery, closing the pericardium is not always required and depends on 
the preference of the surgeon. Although closure of the sternum itself constraints cardi-
ac dilatation, the direct pericardial support potentially contributes to normalizing RA 
function by preventing stretch.  
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Advanced age  
In general AF is known to be age-dependent1, 3, 55 and advanced age is one of the most 
important predictors of POAF, as discussed in chapters 2, 3 and 4. In animal models of 
aging, changes in cellular electrophysiology have been described 56, 57, along with a 
redistribution of gap junctional proteins, interstitial/ endomysial fibrosis, and fatty infil-
tration.58 Thus, aging can lead to an accumulation of structural changes that can lead to 
pro-arrhythmic propagation patterns. 
Hypertension 
Hypertension has also been shown to correlate with interstitial fibrosis leading to het-
erogeneous atrial conduction.59, 60 In a sheep model of longstanding hypertension (15 
months), inflammatory infiltrates in the atrial wall correlated with increased AF induci-
bility and interstitial fibrosis.59 Accordingly, renal denervation for uncontrolled hyper-
tension increases atrial conduction velocity and reduces fractionated activity.61 A previ-
ous study from our group suggests, however, that a protective effect of renal denerva-
tion also occurs in the absence of hypertension. 62 
Obesity 
In a sheep model of obesity, animals were fed a high-calorie diet over 36 weeks and 
underwent electrophysiological and histological study.63 In this model, obesity led to left 
atrial enlargement, increased tissue levels of transforming growth factor- β1 (TGF-β1) 
with increased fibrosis and left atrial fatty infiltration and subsequent pro-arrhythmic 
effects with heterogeneous conduction and enhanced susceptibility to AF.63   
Inflammation 
Another important AF substrate modifier in the context of cardiac surgery is local and sys-
temic inflammation. Inflammation may be pro-arrhythmic through several profibrotic cyto-
kines and atrial structural changes.64 Increased inflammatory biomarkers such as tumor-
necrosis factor- α (TNF-α) have been associated with AF and notably with lone AF.65 TNF- α 
has been shown to increase fibrosis and the profibrotic TGF-β activity in the atrial wall.66  
During cardiac surgery, spatial non-uniformity in refractoriness caused by hypoxia 
and oxidative stress due to insufficient cardioplegic support and insufficient cooling of 
the atria has been hypothesized as an important substrate for development of POAF.67 
In line with this, we found prolonged aortic cross clamp time as an independent predic-
tor of late POAF (chapter 3). Notably, the source of inflammation in patients undergoing 
cardiac surgery is not only the surgical procedure including cardiopulmonary bypass, 
but additional low-grade inflammation may co-exist with the underlying cardiac disease 
itself. For example, in the pathophysiology of coronary artery disease, inflammation 
particularly with increased CRP level plays an essential role contributing to plaque de-
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stabilisation following endothelial dysfunction.68, 69 Also chronic inflammation is a major 
component in the cascade of native aortic valve degeneration. 70 Hence low-grade sys-
temic inflammation goes hand-in-hand with several cardiovascular diseases in the set-
ting of cardiac surgery. In accordance, we found baseline CRP levels combined with 
myocardial infarction as an independent predictor of POAF (Chapter 3).  
In canine sterile pericarditis models, which resemble the acute post cardiac surgery 
setting, dispersion in gap junction distribution with heterogeneous conduction proper-
ties has been demonstrated.9, 71 Also comparable to the systemic effect of cardiopul-
monary bypass, 72 systemic inflammation has been associated with early AF recurrences 
after rhythm control in patients with recent onset persistent AF. 73 As expected, cortico-
steroids have been shown to reduce POAF incidence in a meta-analysis of 50 random-
ised controlled trials 74 indicating the role of inflammation in POAF. However, in a large 
randomised controlled trial, administration of a statin perioperatively reduced postop-
erative low-density lipoprotein and CRP levels but did not affect early POAF incidence.75  
Although these animal models provide insight into pathophysiological mechanisms 
contributing to a structural substrate for AF, it is important to recognize that animal 
models have been used to study a single disease with a sudden onset for a limited dura-
tion, whereas patients most often have several disease factors developing gradually and 
with a more extended duration. 
C o n c l u s i o n  
Patients without a history of AF with several co-morbidities may still carry a complex 
underlying substrate for AF as a result of atrial structural changes. In patients undergo-
ing cardiac surgery, specific co-morbidities aggravating AF susceptibility already co-exist 
with the underlying cardiac diseases. Both CHA2DS2VASc as well as HATCH score are 
important predictors of POAF. In the acute postoperative phase after cardiac surgery, 
this AF substrate is unmasked due to a strong agglomeration of triggers leading to early 
POAF. On the other hand, patients with underlying substrates, perhaps depending on 
the duration of the underlying diseases and treatment compliance, also develop late 
POAF. Importantly, different underlying diseases may affect propagation properties 
differently and complex AF substrates are an accumulation of different co-morbidities 
and their intensity. It is therefore plausible that atrial propagation is negatively affected 
by progressive atrial structural changes towards a critical amount of substrate for-
mation, which then maintains AF when initiated by triggers. These factors show a high 
inter-individual variability contributing to the difficulty to develop relevant classifica-
tions for AF. This variable and progressive AF substrate also indicates the desirability of 
minimally invasive characterization of the AF substrate, such as by P-wave analysis 
(Chapter4) for an optimal, individualized treatment strategy.   
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This thesis highlights the incidence and clinical relevance of late POAF and adds evi-
dence to the notion of opportunities for intensified monitoring of postoperative pa-
tients to increase their health and avoid complication related costs. 
L a t e  P O A F   
Atrial fibrillation after cardiac surgery is the most prevalent complication adding to 
substantial morbidity and clinical costs.1 Patients developing POAF shorter than 48 
hours are discharged without oral anticoagulation and usually without prolonged 
rhythm monitoring. Although symptomatic late POAF episodes may be diagnosed due 
to patient’s complaints, short subclinical episodes are often left undiagnosed and un-
treated. Two important clinical questions regarding POAF recurrences are relevant for 
late POAF, namely the importance of continuous rhythm monitoring and treatment of 
short lasting AF episodes with oral anticoagulation. 
The importance of prolonged continuous rhythm monitoring in AF has recently been 
emphasized in several reports. Intermittent rhythm monitoring strategies such as Holter 
monitoring or periodical electrocardiograms is insufficient to uncover the true AF bur-
den.2, 3 Duration of AF per episode and AF density (i.e temporal clustering of the epi-
sodes) are highly unpredictable in all types of AF.2 This is clearly reflected in clinical 
misclassification of AF, where only 47% of paroxysmal AF and 32% of persistent AF are 
correctly categorized.4 In addition, a large amount of silent strokes result from AF. To 
quantify the incidence of silent stroke in AF patients, one study conducted cerebral 
magnetic resonance imaging (MRIc) of AF patients and compared them to sinus rhythm 
patients.5 The authors showed that 89% of patients with pAF and 92% of pers AF pa-
tients (n= 90 in each group) had underlying silent cerebral ischemia (SCI). Interestingly, 
46% of SR group also had SCI. Although significantly less than AF patients, this remains a 
high percentage of undiagnosed subtle brain damage, which at least partly may corre-
late to asymptomatic AF. 5 6, 7 Indeed, asymptomatic AF is usually detected after a 
stroke episode 8 and using continuous monitoring, asymptomatic AF has been shown to 
explain a large group of cryptogenic strokes with a median AF detection rate of 41 days 
after the stroke,9 further emphasizing the importance of long-term continuous monitor-
ing due to heterogeneous AF density. In line with these findings, we found that the 
majority of patients without a history of AF also show recurrences of POAF lasting 
minutes to hours, after discharge from the hospital.  
Interestingly, patients with late POAF in addition to early POAF had higher 
CHADS2VAS2c scores. This raises the question of treating short lasting AF episodes, 
which is still debated. However, accumulating evidence inclines towards anticoagulation 
treatment for patients with short lasting subclinical AF episodes. First, AF maintains a 
systemic hypercoagulable state 10 and considering the trias of Virchow, at least in pa-
tients with endothelial damage, even short paroxysm of AF may expose the patient to 
 136 
risk of stroke. In accordance, subclinical AF episodes in diabetic patients doubled the 
chances of subclinical infarct (up to 60%) and stroke compared to diabetics without 
AF.11 Also, recent studies have shown higher hypercoagulability markers, a so called 
“pro-thrombotic” state, in young paroxysmal AF patients with CHADS2VAS2c of 0 com-
pared to patients without AF emphasizing the hypercoagulable state caused by AF.12 
Furthermore, 15 minutes of AF in paroxysmal AF patients significantly increases the 
levels of platelet activation, thrombin activation and inflammation in the atria compared 
to patients without AF.13 In addition, as discussed in chapter 4, subclinical AF episodes 
detected by continuous rhythm monitoring lasting more than 5-6 minutes are associat-
ed with ischemic stroke or systemic embolization.3, 14 These findings imply that both 
clinical AF, as well as clinical ischemic stroke, are not sufficient or reliable outcomes for 
decision making regarding patients long-term treatment. For this reason it is desirable 
to closely follow patients prone to AF during the months and years after the operation. 
If AF is detected, intensified monitoring may be adequate and as soon as an AF episode 
is diagnosed on ECG or Holter anticoagulant therapy should be considered. Further-
more, rhythm follow-up enables to investigate the effects of therapy on individual pa-
tients. This is nowadays possible because of the ease and efficiency level of continuous 
rhythm monitoring devices. Interestingly, detecting AF episodes using an i-phone elec-
trocardiogram application was recently shown to be very feasible and effective and may 
be the next step in the evolution of effective arrhythmia management.15 In addition, 
important outcomes such as silent stroke should also be considered in the decision 
making process. 
M i n i m a l  i n v a s i v e  s u b s t r a t e  d e t e c t i o n  i n  A F  
In addition to continuous rhythm monitoring, adequate substrate quantification may 
contribute to patient selection for further follow up, treatment and perhaps in tailored 
treatment aimed at underlying substrate. We found that patients developing early and 
late POAF carry underlying structural substrate as a result of several co-morbidities 
making minimal invasive techniques to quantify this substrate very attractive. In chapter 
4 we used the electrocardiogram to determine P-wave characteristics predicting POAF. 
Contrary to the direct contact epicardial mapping, the P-wave derived from the ECG 
gives a reflection of propagation of the entire atrial activation.  Lower P-wave amplitude 
and duration was a characteristic of patients developing early and late POAF. Imple-
menting signal averaged P-wave analysis to detect and predict AF episodes is a low cost 
low invasive and potentially very accurate technique. Still more research is required to 
expand the field of ECG based P-wave guided risk stratification in detection and preven-
tion of POAF and AF in general.  
In addition, transmural electrical conduction and a 3D substrate is pronounced in 
remodelled atria and is an important measure of substrate complexity for AF (chapter 
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5). In chapter 6 we describe a method to simplify endo-epicardial mapping during AF 
using phase analysis. Phase analysis of electrograms does not require the time-
consuming process of activation time annotation and is more and more used to analyse 
fibrillation electrograms. The coherence of phase between neighboring electrodes al-
lows quantifying the degree of electrical dissociation between these electrodes and 
thus this technique can also be used for quantifying endo-epicardial electrical dissocia-
tion. By calculating the phase of the unipolar electrograms for each electrode, we found 
that during a measurement of at least 15 seconds, maximum mean phase coherence is 
highest between closest electrodes on the opposing side (average of 2,3 mm localiza-
tion error). As expected, we found that there was almost never complete phase coher-
ence between endo-epicardially opposing electrodes, (figure 4 of chapter 6) further 
emphasizing our findings in chapter 5 where endo-epicardial activation time differences 
were never completely zero. We also found that phase coherence decays with distance 
between electrodes. This suggests that dissociated activity is heterogeneously distribut-
ed between endo- and epicardium and is not a temporary phenomenon (considering at 
least the mapped area). If dissociation would be a transient phenomenon, then phase 
coherence at least with distant electrodes (further than the dissociated region) would 
reach a plateau and remain constant. This is clearly not the case as seen in figure 3 of 
chapter 6. Nevertheless, maximum mean phase coherence detects the opposing elec-
trode in longstanding AF patients with endo-epicardial files lasting 15 seconds or longer. 
In other words, there is a correlation between phase of electrograms and the distance 
between the electrodes. This technique may contribute to electrode localization on the 
opposing sites of the atrial wall even in electrically remodeled areas and thus become 
particularly of interest in quantifying individual substrates for AF for tailored treatment 
approaches. 
In conclusion, for an effective and tailored AF treatment, detection of the severity of 
the underlying substrate correlating with true AF burden is mandatory. Future research 
should take primary outcomes such as subclinical short lasting AF episodes and silent 
strokes into consideration. Modern technology offers solutions for these challenges 
including enhanced rhythm follow-up with low burden devices independent of patient 
compliance (ILRs) and minimal-invasive substrate detection and stratification based on 
low cost low burden diagnostic systems (ECGs). 
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Atrial fibrillation occurs in the first few days after cardiac surgery (postoperative atrial 
fibrillation, POAF) as a result of acute-phase triggers. Although historically thought of as 
a transient arrhythmia, accumulating evidence suggests that POAF is an independent 
predictor of poor survival years after surgery. In addition, there is an association be-
tween POAF occurring in the acute postoperative phase and thromboembolic complica-
tions such as stroke occurring months to years after discharge. This suggests that POAF 
may not be confined to the acute postoperative phase but may be a recurrent subclini-
cal arrhythmia.  
To determine the incidence of AF episodes after discharge, we used continuous 
rhythm monitoring devices to follow patients without a history of AF following their 
open chest cardiac surgical procedure. In Chapter 3 and 4, we describe our results from 
continuous rhythm monitoring for a month and for 3 years respectively. Firstly, we 
found that more than 25% of patients developed AF in the month following discharge 
form hospital, the so-called late POAF (Chapter 3). Predictors of late POAF included co-
morbidities such as prior myocardial infarction, diabetes mellitus, obesitas and baseline 
CRP levels. In chapter 4 we further extended the rhythm-monitoring period to 3 years 
with an implantable loop recorder in patients without a history of AF. We demonstrated 
that up to 50% of patients developed AF episodes lasting 1,5 hours on average during 
the months to years following surgery. Patients who developed late POAF were older 
and had higher CHA2DS2VASc and HATCH scores with right atrial volume as an inde-
pendent predictor of late POAF. Our findings in these chapters suggest that the risk 
profile for POAF and notably for late POAF resembles the risk profile of AF in general 
including a structural substrate for AF.  
The complexity of the atrial structural substrate is reflected by the complexity of 
electrical conduction during induced AF. Patients with several cardiovascular co-
morbidities (high CHA2DS2VASc scores), show enhanced level of pathological atrial wall 
changes leading to complex fibrillating patterns during AF. To explore the electrophysio-
logical substrate for POAF, we measured the complexity of fibrillating patterns of elec-
trically induced AF on the right atrial wall (Chapter 4). For this purpose we induced AF 
during cardiac surgery by burst pacing and mapped the electrical activation of the right 
atrium using a 256 unipolar electrode plaque. In line with the previous findings, we 
found more complex activation patterns (i.e. higher number of waves and fractionation 
index) in patients who subsequently developed POAF and also those with late-POAF. 
This illustrates the effects of age and several co-morbidities on the atrial wall, which 
may not have led to (symptomatic) AF prior to surgery but may be prone to develop-
ment of a stronger substrate with time. 
Interestingly, enhanced complexity of the electrophysiological substrate in animal 
models involves higher number of wavelets and higher number of breakthrough waves, 
i.e. waves migrating to the opposing layer of the atrial wall due to dyssynchronous acti-
vation of the endocardium compared with epicardium. To investigate the mechanism of 
transmural propagation of the atrial wall described in animal models, we developed a 
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highly detailed 3 dimensional computer model of the human atria. In this computer 
model, specific atrial anatomical structures were implemented and the mechanism of 
fibrosis related dissociation between endo-epicardial layers was demonstrated. We 
found a clear association between endo-epicardial dissociated activity due to increased 
levels of fibrosis and the number of breakthrough waves. To validate this model, we 
developed a crocodile shaped clamp electrode containing a double layer of unipolar 
electrode plaques. The electrode was designed to be inserted into the right atrium with 
one arm and to be approximated on the atrial wall on both sides. Using this technique, 
we were able to quantify for the first time in human, the amount of electrical uncou-
pling between the two layers of the atrial wall. We found that the endo-epicardial dis-
sociation is enhanced with complex substrates for AF. In addition, there is indeed a clear 
correlation between endo-epicardial dissociation and the number of waves migrating to 
the opposing layer of the atrial wall, the so-called breakthrough waves. To further eluci-
date on these findings, we describe in Chapter 6 a method to detect the location of 
electrodes on the opposing side of the atrial wall by measuring the phase of depolariza-
tion during AF. We were able to demonstrate that mean-phase coherence between 2 
electrodes, decays with distance between them. This method may be helpful in detect-
ing the 3-D substrate of AF less invasively.  
In conclusion, using continuous rhythm monitoring strategies combined with base-
line substrate quantification in patients without a history of AF we found up to 50% late 
POAF recurrences. Patients developing late POAF were older with additional co-
morbidities and showed a more complex fibrillation pattern during electrically induced 
AF compared to those who did not develop POAF. In addition, we sought for the effects 
of atrial structural substrate on endo-epicardial dissociation and found a correlation 
between enhanced electrical dyssynchrony and breakthrough waves in a computer 
model of human atria. We also demonstrated the 3D substrate for AF in human by di-
rect contact endo-epicardial mapping. Future research should determine the clinical 
consequences of late POAF and the range of the underlying structural substrate, which 
predisposes patients to AF development.  
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Het hart bestaat uit 2 boezems en 2 kamers. De boezems vullen de kamers van bloed 
waarna de kamers bloed rondpompen naar de rest van het lichaam. Een ritmestoornis 
waarbij de boezems (atria) niet meer contraheren en het bloed niet meer adequaat 
naar de kamers kunnen pompen wordt boezemfibrilleren of atrium fibrilleren (AF) ge-
noemd. De klachten die hiermee samenhangen zijn hartkloppingen, kortademigheid en 
pijn op de borst. Boezemfibrilleren is soms ook aanwezig zonder enige symptomen en 
wanneer het niet ontdekt en niet behandeld wordt, verhoogt het de risico op hersenin-
farcten en hartfalen.  
Na een open hartoperatie ontstaat AF met name in de eerste paar dagen na de ope-
ratie. Dit wordt postoperatief AF (POAF) genoemd. Hoewel altijd gedacht werd dat 
POAF van voorbijgaande aard was, bleken patiënten die de ritmestoornis wel ontwikke-
len, in de jaren na ontslag uit het ziekenhuis ook eerder te overlijden vergeleken met 
patiënten die dit niet ontwikkelen. Om te achterhalen waarom patiënten die POAF ont-
wikkelen slechtere overleving laten zien, hebben wij in dit proefschrift onder andere 
onderzoek gedaan naar 2 vragen.  
Ten eerste is de vraag of POAF een voorbijgaande ritmestoornis is, of komt het 
maanden tot jaren na ontslag uit het ziekenhuis toch weer terug, een zogenaamde late 
POAF. Ten tweede is de vraag welke patiënten hier het meest vatbaar voor zijn.  
De eerste vraag hebben wij onderzocht door patiënten die niet bekend waren met 
boezemfibrilleren te volgen nadat zij een open hartoperatie hadden ondergaan. Dit 
hebben wij gedaan op twee manieren. Eerst hebben wij speciaal ontworpen draagbare 
apparaten gebruikt die het ritme van de patiënten continu kunnen detecteren gedu-
rende een maand (Hoofdstuk 3). Daarnaast hebben wij een tweede groep patiënten 
gedurende 3 jaar gevolgd via een chip die onder de huid werd geïmplanteerd met de-
zelfde ritme detectie functie (Hoofdstuk 4). In hoofdstukken 3 en 4 hebben wij de resul-
taten van deze twee technieken beschreven. Continue ritme monitoring liet in beide 
studies zien dat meer dan 30% van de patiënten die nooit tevoren symptomen van AF 
hadden, na ontslag uit het ziekenhuis alsnog POAF ontwikkelden. Nadat wij patiënten 3 
jaar gevolgd hadden, zagen wij dat maar liefst 50% van de patiënten jaren na de opera-
tie wederom kortdurende episoden van  POAF ontwikkelden. De conclusie van deze 
studies was dat POAF geen voorbijgaande ritmestoornis is zoals vooraf gedacht werd.  
Een tweede vraag die logischerwijs op de eerste vraag volgt, is welke kenmerken 
bepalend zijn voor late POAF ontwikkeling. Wij hebben dus uitgebreid onderzoek ge-
daan naar de zogenaamde voorspellers van POAF en de vatbaarheid van patiënten 
hiervoor.  
De belangrijkste voorspeller van POAF en late POAF is hogere leeftijd (Hoofdstuk 4).  
Het is bekend dat door hogere leeftijd de structuur van de boezemwand langzaam ver-
andert wat een belangrijk effect heeft op de regelmaat van boezem activatie en dus de 
ritme van het hart. Oudere patiënten hebben bovendien specifieke ziektebeelden zoals 
hypertensie, suikerziekte en overgewicht, ziektebeelden die ook rechtstreeks effecten 
uitoefenen op de kans op AF.  
 150 
Een belangrijk neveneffect van de structuur veranderingen van de boezems is dat de 
elektrische geleiding over de boezems ook onregelmatig en chaotisch  verloopt ten 
opzichte van een relatief eenvoudige patroon van activatie bij normale boezems. Om 
deze elektrische eigenschappen van de “zieke” boezems te achterhalen hebben wij 
gebruik gemaakt van speciaal ontworpen elektrodes die tijdens open hartoperaties op 
of in het hart werden gepositioneerd terwijl boezemfibrilleren werd opgewekt met 
behulp van een pacemaker. Wij vonden dat vooral in patiënten met POAF, de elektri-
sche geleiding veel complexer en meer chaotisch was dan bij patiënten zonder POAF. 
Met andere woorden, door ouderdom en de ziektebeelden die ermee samengaan, 
hebben patiënten dusdanig beschadigde boezems ontwikkeld (een zogenaamd sub-
straat voor AF), die (onder stimulatie) vatbaar kunnen zijn voor het ontwikkelen van 
boezemfibrilleren. Dit betekent dus ook dat gezien de vatbaarheid, deze patiënten niet 
alleen boezemfibrilleren ontwikkelen tijdens opname in het ziekenhuis, maar eveneens 
het risico lopen om later na ontslag uit het ziekenhuis opnieuw boezemfibrilleren te 
ontwikkelen.  
Om de effecten van ouderdom en ziektebeelden op de elektrische geleiding van de 
boezems verder te onderzoeken hebben wij een anatomisch computer model ontwik-
keld waarin wij deze eigenschappen konden nabootsen. We vonden dat afhankelijk van 
de ernst van de beschadiging van de boezems er ook een toenemend asynchrone gelei-
ding plaatsvindt over de binnen en buitenwand van de boezems. Dit leidt er vervolgens 
toe dat steeds meer elektrische activatie vanuit de binnenzijde van de boezemwand ook 
naar buitenzijde kan geleiden en andersom. Hoe minder synchroon de buiten- en bin-
nenzijde van de boezems geactiveerd worden, hoe meer elektrische activatie tussen de 
twee lagen wordt voortgeleid. Met andere woorden, naar mate de boezems beschadigd 
raken als gevolg van verschillende ziektebeelden (substraat), verbreekt de synchronisatie 
tussen de binnen en buitenwand van de boezems en ontstaat een 3 dimensionale elek-
trische geleiding die bijdraagt aan de complexe patroon van de elektrische geleiding. 
In hoofdstukken 4 en 6 beschrijven wij enkele technieken waarin met behulp van 
minimaal invasieve methodes een eventueel substraat voor boezemfibrilleren gedetec-
teerd kan worden. Zo werden in hoofdstuk 4, P-golf eigenschappen in een standaard 
ECG besproken die kenmerkend waren voor patiënten die late POAF ontwikkelden. 
Deze technieken kunnen relatief eenvoudig voorspellen bij welke patiënten reeds een 
substraat bestaat en aldus behandeling voor late POAF aan te bevelen is. Uiteraard zijn 
deze technieken nog in kinderschoenen en zou meer onderzoek hiernaar de klinische 
toepasbaarheid ervan kunnen vergroten.  
Concluderend kunnen wij stellen dat boezemfibrilleren na een hartoperatie een ui-
ting is van de onderliggende ernst van de beschadiging van de boezemwand (substraat). 
Dit leidt ertoe dat boezemfibrilleren na een open hartoperatie zich niet beperkt tot het 
ziekenhuisopname maar in de maanden tot jaren na ontslag uit het ziekenhuis ook kan 
terugkeren. Verder onderzoek zal moeten uitwijzen op welke wijze de uitingen van dit 
substraat behandeld of zelfs voorkomen zouden kunnen worden.   
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 De Universiteit Maastricht onderscheidt zich door een innovatief onderwijs model, 
het probleem gestuurd onderwijs, waarin de student al vroeg in de studie gefaciliteerd 
wordt om in aanraking te komen met de kliniek en het wetenschap. Ik heb deze moge-
lijkheden gekregen binnen Cardiovascular Research Institute Maastricht een van de 
grootste cardiovasculaire onderzoeksinstellingen binnen Europa. Hierbinnen  bestaan 
unieke samenwerkingen tussen verschillende specialismen, onder andere de afdelingen 
Fysiologie (Prof Schotten), Cardiologie (Prof Crijns) en Cardio-Thoracale Chirurgie (Prof 
Maessen) wat een platform heeft gecreëerd voor open en innovatief wetenschappelijk 
onderzoek en hier begint het voor velen. 
 Op de eerste plaats gaat mijn dank uit naar Prof Schotten, Uli (“Niet bang zijn voor je 
negatieve resultaten”…”Het gaat om de boodschap”) die mij niet alleen het belang van 
kwaliteit heeft bijgebracht, maar nog belangrijker, het belang van mijden van concessies 
doen aan kwaliteit, hetgeen bewerkstelligd wordt door informatie onbevooroordeeld 
en onafhankelijk op zijn waarde te schatten. De weg leidt dan automatisch naar creativi-
teit, zorgvuldigheid en meer inzicht. Ik hoop van harte dit proces met zijn hulp verder te 
mogen uitdiepen.  
 Alweer 10 jaar geleden heb ik kennis gemaakt met Prof Maessen (“blijf op het juiste 
vlak”… “wees niet zuinig op de lat”)  die mij in de loop der jaren gestimuleerd heeft om 
verder te kijken en geïnspireerd heeft om grenzeloos te denken m.n. rondom innovatie 
en opleiding. Het vereist hoge mate van kennis om zijn helikopter view voor te stellen 
maar gelukkig gaat dat samen met veel betrokkenheid en staat zijn deur altijd open (en 
zijn GSM)! Ik hoop ook met name op een voortzetting van onze muzikale avonturen. 
 Ik ben Sander Verheule (“maar… je kan het ook anders zien…”) dankbaar voor zijn 
ingenieus non-conformistische inbreng welke onmisbaar is in ieder project. Dit betekent 
dat hij vaak als enige het lichtpuntje ziet. Zijn Maverick status wordt alleen al bevestigd 
door het feit dat hij in 2018 zijn eerste smartphone heeft aangeschaft en ik ben blij dat 
hij mijn co-promotor wilde zijn. 
 Ik zou graag de leden van de leescommissie Prof Crijns, Prof Van Gelder, Prof Suyker 
en Prof La Meir willen bedanken voor het kritisch beoordelen van dit werk en voor het 
afleggen van lange afstanden om bij de verdediging aanwezig te zijn.  
 Diepgaande discussies en een open feedback cultuur kenmerken de geweldige re-
searchgroep waarin onder andere Stef Zeemering, Arne van Hunnik, Ali Gharaviri, Theo 
Lankveld, Dennis Lau en Pawel Kuklik  mij hebben begeleid…We’ll always have Denver! 
 Ik ben de staf Cardio-Thoracale Chirurgie van Maastricht UMC+ dankbaar voor hun 
toegankelijkheid en geduld, kwaliteiten die keer op keer op de proef werden gesteld 
tijdens wetenschappelijke activiteiten maar ook tijdens opleidingsmomenten. Daarnaast 
ben ik erg verwend geraakt in mijn opleiding door de verfrissend moderne opvattingen 
met name van mijn opleidster Dr Suzanne Kats (“kom op…even flink zijn!”), Dr Ehsan 
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Natour (“nooit compromissen accepteren tijdens opereren!”), Dr Peyman Sardari Nia 
(“Het draait altijd om perfectie!”), Dr Patrique Segers (“als je iets efficiënter had ge-
werkt waren wij nu allang thuis”), Dr Gijs Geskes ( “De betere chirurg weet wie hij niet 
moet opereren.”), Prof. dr. Bas Mochtar (“communiceren en documenteren!”) en Prof. 
dr. Roberto Lorusso (“remember...it’s all about details!”), allen met een eigen heldere 
filosofie betreffende  cardiochirurgie dat mij altijd zal bijblijven.   
 In het diepe werd er voor verlichting gezorgd door Marcel van der Linden, Bart Mae-
sen, Reinier Zandbergen en Ryan Accord, allen als mijn begeleiders als medisch student 
en later arts-assistent en ik waardeer de vriendschappen die hieruit zijn ontstaan. Het-
zelfde geldt voor Stefan Verstraeten, Pieter Lozekoot, Lars van Middendorp, Rick 
Schreurs, Sam Heuts en Martijn Gilbers, allen wil ik bedanken voor hun inzet en bijdrage 
ook na het werk, vaak tot in de kleine uurtjes. Ellen Heerdt en Martijne Tromp hebben 
op het gebied van patiënt contacten en Reveal implantaties het meeste werk verricht! 
Daarnaast hebben vele studenten bijgedragen aan het verzamelen van data. 
 Mijn dank gaat verder uit naar de betrokken anesthesiologen voor hun geduld tij-
dens rapid-pacing op de operatiekamer en de intensivisten tijdens pacing op de intensi-
ve care. Ik ben erg veel geholpen door de creatieve oplossingen geboden door de ope-
ratieverpleegkundigen tijdens mapping op de OK.  Sylvia, Nicole, Lucien en Anja ben ik 
dankbaar voor hun onmisbare ervaring en inzet in de planning. Alle secretaressen o.a. 
Bianca, Vivian, Lysette, Nadine en Monique hebben gezorgd voor de onvermijdelijke 
logistiek. Tussen 2010 en 2015 hebben meer dan 250 patiënten toestemming gegeven 
om mee te doen aan een onderzoek. Zonder deze vrijwilligers was dit onderzoek onmo-
gelijk geweest.  
 De horizon werd steeds breder met vrienden als Parwez & Farnaz, Ehsan & Nargis 
en Eduard & Bernice!  
 Door de onvoorwaardelijke liefde van mijn ouders, ondanks de vele uitdagingen in 
hun leven, sta ik waar ik sta en is dit boekje uiteraard aan hun opgedragen. Ik ben bij-
zonder trots op mijn broertje Bahram en zusjes Elaha en Sadaf en de nieuwste leden 
Jorrin en de kleine Naeva…zij zijn de veilige thuisbasis waar ik altijd kan landen. 
Finally, I would like to thank my wife, Karina who has ben a constant support and a true 
motivation, with an unconditional smile on her face…я люблю тебя!  
Milan en Amir zijn zonder twijfel de belangrijkste inspiratiebronnen in mijn leven.  
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